Wayne L. Hofstetter, M.D.

Peer-Reviewed Articles

1. Folkert IW, Mehran R, Sun R, Morris VK, Overman MJ, Kee B, Antonoff MB, Tzeng CW, Dasari A, Tran Cao H, Parseghian CM, Vilar E, Willis J, Newhook TE, Hofstetter W, Kopetz SE, Vauthey JN, Chun YS. Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial 33(4):2899-2907, 2026. e-Pub 2026. PMID: 41369813.
2. Hooda, Z, Ries, S, Eisenberg, M, Werner, R, Hofstetter, WL, Mehran, RJ, Rajaram, R, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Opitz, I, Mitchell, KG, Antonoff, MB. Local Consolidative Surgery for Oligometastatic Non-Small Cell Lung Cancer With Bone Metastasis. Annals of Thoracic Surgery Short Reports 4(1):196-200, 2026. e-Pub 2026.
3. Tomita K, Smith PM, Takayama M, Pan C, Shen SE, Wang X, Wang XS, Williams LA, Arvide EM, To C, Rajaram R, Mitchell KG, Rice DC, Hofstetter WL, Antonoff MB, Mehran RJ, Vaporciyan AJ, Walsh GL, Maxwell JE, Snyder RA, Kim MP, Tzeng CD, Mansfield PF, Swisher SG, Lee JE, Badgwell BD, Katz MHG, Ikoma N. ASO Visual Abstract: Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-Surg. e-Pub 2026. PMID: 41849121.
4. Marincola Smith, P, Tomita, K, Cass, SH, Hirata, Y, Pan, C, Shen, SE, Wang, X, Wang, XS, Williams, LA, Arvide, M, To, C, Rajaram, R, Rice, DC, Hofstetter, WL, Antonoff, MB, Mehran, RJ, Vaporciyan, AA, Walsh, GL, Maxwell, JE, Snyder, RA, Kim, M, Tzeng, CD, Badgwell, BD, Mansfield, PF, Katz, MH, Swisher, SG, Lee, JE, Ikoma, N. Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers. Annals of surgical oncology 33(2):1332-1342, 2026. e-Pub 2026. PMID: 41057745.
5. Hooda, Z, Ries, S, Fabian, T, Freeman, KA, Hofstetter, WL, Hudson, J, Mehran, RJ, Rajaram, R, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Mitchell, KG, Zaku, B, Antonoff, MB. Training left-handed cardiothoracic surgeons in a right-handed world. JTCVS Open 29, 2026. e-Pub 2026.
6. Marincola Smith P, Tomita K, Cass S, Hirata Y, Pan C, Shen SE, Wang X, Wang XS, Williams LA, Arvide M, To C, Rajaram R, Rice D, Hofstetter W, Antonoff M, Mehran R, Vaporciyan A, Walsh G, Maxwell J, Snyder R, Kim M, Tzeng CD, Badgwell B, Mansfield P, Katz M, Swisher S, Lee J, Ikoma N. Psychometrice Validation of a New Module of MD Anderson Symptom Inventory (MSASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg. Ann Surg Oncol 33(2):1332-1342, 2026. e-Pub 2025. PMID: 41057744.
7. Deboever N, Khanduri I, Eisenberg M, Mehran RJ, Rajaram R, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Maru DM, Hofstetter WL. Mucosal Versus Submucosal Lymphovascular Invasion in Early Esophageal Cancer. e-Pub 2026. PMID: 41699353.
8. Zhou N, Niu J, Nelson D, Feldman HA, Antonoff MB, Hofstetter WL, Mehran RJ, Dc R, Sepesi B, Swisher SG, Walsh GL, Giordano SH, Rajaram R. Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection. e-Pub 2026. PMID: 36801207.
9. Nieto Y, Ward JF, Hofstetter W, Rice D, Karam JA, Pisters L, Vauthey JN, Shah A, Lin JK, Johns AC, Araujo J, Tu SM, Wang J, Li J, Abudayyeh A, Thall PF, Bassett R, Barnett M, Gulbis A, Shigle TL, Ramdial J, Popat U, Qazilbash M, Jones RB, Andersson BS, Shpall EJ, Sheikh I, Pagliaro L, Campbell MT. High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clin Cancer Res 32(2):300-311, 2026. e-Pub 2026. PMID: 40853903.
10. Hooda Z, Werner R, Ries S, Eisenberg M, Hofstetter WL, Mehran R, Rajaram R, Rice DC, Swisher S, Vaporciyan AA, Walsh G, Opitz I, Mitchell KG, AntonoffMB. Role of Genetic Alterations on Outcomes for Pulmonary Resection in Oligometastatic Non-small Cell Lung Cancer. J Thorac Dis 17(12):10636-10647, 2025. e-Pub 2025. PMID: 41522142.
11. Deboever N, Khanduri I, Eisenberg M, Mehran RJ, Rajaram R, Rice DC, Roth J, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MG, Maru DM, Hofstetter WL. Mucosal Versus Submucosal Lymphovascular Invasion in Early Esophageal Cancer. e-Pub 2025.
12. Folkert IW, Mehran R, Sun R, Morris VK, Kee B, Antonoff MB, Tzeng CW, Dasari A, Tran Cao H, Parseghian CM, Vilar E, Willis J, Newhook TE, Hofstetter WL, Kopetz SE, Vauthey JN, Chun YS. Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Live and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. e-Pub 2025. PMID: 41369812.
13. Andrews WG, Blitz S, Sewell M, Molena D, Hofstetter WL, Yeung J, Darling GE, Sharata A, DeMeester SR, Peyre CG, Dunn C, Lipham JC, Bograd AJ, White PT, Farivar AS, Louie BE. The Location and Degree of Residual Disease Determines Recurrence Patterns and Survival in Patients With Esophageal Adenocarcinoma After Trimodal Therapy. Diseases of the Esophagus 38(6):doaf125, 2025. e-Pub 2025. PMID: 41432948.
14. Betancourt Cuellar SL, Benveniste MF, Palacio D, Atiyah A, Hofstetter WL, Erasmus JJ. Is 18F-FDG-PET/CT Useful in Staging of Locally Advanced Signet-Ring Cell Esophageal Adenocarcinoma. Clin Imaging 125:110545, 2025. e-Pub 2025. PMID: 40517563.
15. Molena, D, Sewell, M, Maron, SB, Hofstetter, WL, Worrell, SG, Chen, K, Enzinger, PC, Gerdes, H, Kleinberg, L, Murthy, SC, Palta, M, Pouw, RE, Reddy, RM, Sanford, DE, Schumacher, LY, Sihag, S, Berry, MF. The 2025 American Association for Thoracic Surgery (AATS) expert consensus document. Journal of Thoracic and Cardiovascular Surgery 170(3):884-901.e3, 2025. e-Pub 2025. PMID: 40328426.
16. Molena D, Sewell M, Maron SB, Hofstetter WL, Worrell S, Chen KN, Enzinger PC, Gerdes H, Kleinberg L, Murthy S, Palta M, Pouw RE, Reddy RM, Sanford DE, Schumacher L, Sihag S, Mf B. The 2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical Management of Esophageal and Gastroesophageal Junction Cancer. J Thorac Cardiovasc Surg 170(3):884-901, 2025. e-Pub 2025. PMID: 40328425.
17. Hooda, Z, Duan, Z, Ries, S, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Mitchel, KG, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Rajaram, R. Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients. Annals of Thoracic Surgery 120(2):401-410, 2025. e-Pub 2025. PMID: 40222577.
18. Deboever, N, Al Tashi, Q, Eisenberg, M, Saad, M, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Rice, DC, Roth, JA, Swisher, SG, Vaporciyan, AA, Walsh, GL, Wu, J, Rajaram, R. Machine Learning Prediction of Financial Toxicity in Patients with Resected Lung Cancer. Journal of the American College of Surgeons 241(2):107-116, 2025. e-Pub 2025. PMID: 40028915.
19. Hooda Z, Duan Z, Ries S, Antonoff MB, Hofstetter WL, Mehran R, Mitchell KG, Rice D, Swisher S, Vaporciyan AA, Walsh G, Rajaram R. .Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients. Ann Thorac Surg 120(2):401-410, 2025. e-Pub 2025. PMID: 40222576.
20. Deboever N, Al-Tashi Q, Eisenberg M, Saad MB, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Swisher SG, Vaporciyan AA, Walsh GL, Wu J, Rajaram R. Machine Learning Prediction of Financial Toxicity in Patients With Resected Lung Cancer 241(2):107-116, 2025. e-Pub 2025. PMID: 40028915.
21. Nieto Y, Ward JF, Hofstetter WL, Rice D, Karam JA, Pisters L, Vauthey JN, Shah A, Lin JK, Johns AC, Araujo J, Tu SM, Wang J, Li J, Abudayyeh A, Thall PF, Bassett R, Barnett M, Gulbis A, Shigle TL, Ramdial J, Popat U, Qazibash M, Jones RB, Andersson BS, Shpall EJ, Sheikh I, Pagliaro L, Campbell MT. High -Dose Chemotherapy For Multiply or Poor-Risk Relapsed Germ-Cell Tumors. e-Pub 2025. PMID: 40853902.
22. Eisenberg MA, Werner R, Ries S, Hofstetter WL, Mehran RJ, Papasotiropoulos T, Rice DC, Rajaram R, Steinmann N, Swisher SG, Walsh GL, Vaporciyan AA, Opitz I, Anonoff MB. Extent of Resection in Surgically Resected Stage IV Non-Small-Cell Lung Cancer: Results from Two Tertiary Referral Centers. J Thorac Cardiovasc Surg 170(2):359-368, 2025. e-Pub 2025. PMID: 40280541.
23. Markar SR, Van Berge Henegouwen M, Bruns C, Ferri L, van Hillegersberg R, Hofstetter WL, Nilsson M. SANO Trial: Innovations, Risks and Unanswered Questions. Lancet Oncology 26(7):e338, 2025. PMID: 40609578.
24. Hofstetter WL. Commentary: Clinical T1b Esophageal Cancer is Not Always What it Seems. J Thorac Cardiovasc Surg 169(6):e69-e70, 2025. e-Pub 2024. PMID: 39208928.
25. Hofstetter WL, Feng L, Bonini F, Sousa LG, Wang K, Siqueira JM, Nguyen Q, El-Nagger AK, Hofstetter WL, Sepesi B, Ferrarotto R. Survival Outcomes of Pulmonary Metastasis-Directed Local Therapy in Adenoid Cystic Carcinoma. Cancer 15(131):e35901, 2025. e-Pub 2025. PMID: 40377125.
26. Ajani JA, D'Amico TA, Bentrem DJ, Corvera CU, Das P, Enzinger PC, Enzler T, Gerdes H, Gibson MK, Grierson P, Gupta G, Hofstetter WL, Ilson DH, Jalal S, Kim S, Kleinberg LR, Klempner S, Lacy J, Lee B, Licciardi F, Lloyd S, Ly QP, Matsukuma K, McNamara M, Merkow RP, Miller AM, Mukherjee S, Mulcahy MF, Perry KA, Pimiento JM, Reddi DM, Reznik S, Roses RE, Strong VE, Su S, Uboha N, Wainberg ZA, Willett CG, Woo Y, Yoon HH, McMillian NR, Stein M. Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network 23(5):169-191, 2025. e-Pub 2025. PMID: 40341199.
27. Markar SR, Van Berge Henegouwen M, Bruns C, Ferri L, van Hillegersberg R, Hofstetter WL, Nilsson M. Does the SANO Trial Really Move Us Toward Organ Preservation for Esophageal Cancer?. Dis Esophagus 38(3):doaf049, 2025. e-Pub 2025. PMID: 40526374.
28. Deboever N, Eisenberg M, Niu J, Graber W, Antonoff MB, Hofstetter WL, Mehran RJ, Swisher SG, Vaporciyan AA, Walsh GL, Giordano SH, Rajaram R, Rice DC. Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB. Journal of surgical oncology 131(5):793-803, 2025. e-Pub 2024. PMID: 39635913.
29. Deboever N, Eisenberg M, Niu J, Graber W, Antonoff MB, Hofstetter WL, Mehran RJ, Swisher SG, Vaporciyan AA, Walsh GL, Giordano SH, Rajaram R, Rice DC. Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB. J Surg Oncol 131(5):793-803, 2025. e-Pub 2025. PMID: 396385912.
30. Eisenberg, M, Deboever, N, Hofstetter, WL, Mehran, RJ, Rice, DC, Rajaram, R, Swisher, SG, Vaporciyan, AA, Walsh, GL, Antonoff, MB. Pulmonary Surgical Margins for Metastatic Osteosarcoma. Annals of Thoracic Surgery 119(3):616-624, 2025. e-Pub 2025. PMID: 38839027.
31. Hofstetter WL, Deboever N, Al-Tashi Q, Eisenburg M, Saad MB, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Swisher SG, Vaporciyan AA, Walsh GL, Wu J, Rajaram R. Machine Learning Prediction o Financial Toxicity in Patients with Resected Lung Cancer. J Am Call Surg. e-Pub 2025. PMID: 40028914.
32. Eisenberg M, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?. Ann Thorac Surg. e-Pub 2025. PMID: 38839027.
33. Deboever N, Eisenberg MA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer. Journal of surgical oncology 131(2):303-309, 2025. e-Pub 2024. PMID: 39257253.
34. Abana, CO, Carriere, P, Damen, PJ, van Rossum, P, Yoder, A, Bravo, PL, Wei, X, Pollard-Larkin, JM, Nitsch, PL, Murphy, MB, Hofstetter, WL, Liao, Z, Lin, SH. Comparative Outcomes and Toxicity in Patients With Esophageal Cancer After Trimodality Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy. Clinical Oncology 38, 2025. e-Pub 2025. PMID: 39706143.
35. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC. Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Communications Medicine 4(1), 2024. e-Pub 2024. PMID: 38796532.
36. Zhou N, Leung CH, Jr WW, Weissferdf A, Pataer A, Godoy MCB, Carter BW, Fossella FV, Tsao AS, Blumenschein GR, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Tran HT, Wu J, Solis Soto LM, Kadara H, Swisher SG, Vaporciyan AA, Gibbons DL, Lin HY, Lee JJ, Heymach JV, Negrao MV, Sepesi B, Cascone T. Impact of Select Actionable Genomic Alterations on Efficacy of Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer. J Immunother Cancer 12(10):e009677, 2024. e-Pub 2024. PMID: 39448200.
37. Markar SR, Sgromo B, Evans R, Griffiths EA, Alfieri R, Castoro C, Gronnier C, Gutschow CA, Piessen G, Capovilla G, Grimminger PP, Low DE, Gossage J, Gisbertz SS, Ruurda J, van Hillegersberg R, D'journo XB, Phillips AW, Rosati R, Hanna GB, Maynard N, Hofstetter WL, Ferri L, Berge Henegouwen MI, Owen R. The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE Study. Ann Surg 280(4):650-658, 2024. e-Pub 2024. PMID: 38904105.
38. Mitchell KG, Feldman H, Milton DR, Antonoff MB, Hofstetter WL, Rice DC, Vaporciyan AA, Lin R, Thall PF, Rajaram R, Group MD. Signet Ring Cells and Conditional Survival After Trimodality Therapy for Esophageal Adenocarcinoma. Journal of surgical oncology 130(3):428-434, 2024. e-Pub 2024. PMID: 39004940.
39. Deboever N, Eisenberg MA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer. J Surg Oncol. e-Pub 2024. PMID: 39257253.
40. Hofstetter WL. Early Interventional Treatment of High Output Chyle Leak following Esophagectomy is Associated with Improved Survival. Ann Surg 280(1):91-97, 2024. e-Pub 2024. PMID: 38568206.
41. Goltsov AA, Maru DM, Katkhuda R, Duose DY, Luthra R, Correa AM, Wang F, Futreal AP, Hofstetter WL. ANPEP/CD13 Expression as Marker of Lymphovascular Invasion and Survival in Esohageal Adenocarcinoma. Ann Thorac Surg 118(1):241-251, 2024. e-Pub 2023. PMID: 37806335.
42. Antonoff MB, Kui N, Sun R, Deboever N, Hofstetter WL, Mehran RJ, Morris VK, Rice DC, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Factors Associated with Receipt of Pulmonary Metastasectomy in Patients with Lung-Limited Metastatic Colorectal Cancer: Disparities in Care and Impact on Overall Survivall. J. Thorac Cardiovasc Surg 168(1):263-271, 2024. e-Pub 2023. PMID: 37690624.
43. Fick CN, Dunne EG, Sihag S, Molena D, Cytryn SL, Janjigian YY, Wu AJ, Worrell SG, Hofstetter WL Jones DR, Gray KD. Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma. Ann Thorac Surg 118(1):130-140, 2024. e-Pub 2024. PMID: 28408630.
44. Mitchell KG, Feldman H, Milton DR, Antonoff MB, Hofstetter WL, Rice DC, Vaporciyan AA, Lin R, Thall PF, Rajaram R, Group MD. Signet Ring Cells and Conditional Survival After Trimodality Therapy For Esophageal Adenocarcinoma. J. Surg Oncol. e-Pub 2024. PMID: 39004940.
45. Antonoff MB, Kui N, Sun R, Deboever N, Hofstetter WL, Mehran RJ, Morris VK, Rice DC, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Factors Associated with Receipt of Pulmonary Metastasectomy in Patients With Lung-limited Metastatic Colorectal Cancer: Disparities In Care And Impact On Overall Survival 168(1):263-271, 2024. e-Pub 2023. PMID: 37690624.
46. Zhou, N, Hofstetter, WL. Salvage Esophagectomy. Foregut 4(2):150-157, 2024. e-Pub 2024.
47. Deboever N, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MB. Perioperative and Oncologic Outcomes of Pulmonary Resection for Synchronous Oligometastatic Non-small Cell Lung Cancer: Evidence for Surgery in Advanced Disease. J Thorac Cardiovasc Surg 167(6):1929-1935.e2, 2024. e-Pub 2023. PMID: 37619884.
48. Hofstetter WL. Octreotide's Role in the Management of Post-esophagectomy Chylothorax. Dis Esophagus 37(6), 2024. e-Pub 2024. PMID: 38391198.
49. McKay, SC, Louie, BE, Molena, D, Andrews, WG, Boerner, T, Hofstetter, WL, Yeung, J, Darling, GE, Sharata, A, Peyre, CG, Dunn, C, Lipham, JC, Marginean, H, Demeester, S. Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery 167(6):1943-1950, 2024. e-Pub 2024. PMID: 37788788.
50. Markar SR, Sgromo B, Evans R, Griffith EA, Alfieri R, Castoro C, Gronnier C, Gutschow CA, Piessen G, Capovilla G, Grimminger PP, Low DE, Gossage J, Gisbertz SS, Ruurda J, van Hillegersberg R, D'journo XB, Phillips AW, Rosati R, Hanna GB, Maynard N, Hofstetter W, Ferri L, Berge Henegouwen MI, Owen R. The Prognostic Impact of Minimally Invasive Esophagectomy On Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE Study. Ann Surg. e-Pub 2024. PMID: 38904105.
51. Ohannesian N, Mallick MS, He J, Qiao Y, Li N, Shaitelman SF, Tang C, Shinn EH, Hofstetter WL, Goltsov A, Hassan MM, Hunt KK, Lin SH, Shih WC. Author Correction: Plasmonic Nano-aperture Label-free Imaging of Single Small Extra Cellular Vesicles for Cancer Detection, 2024. e-Pub 2024. PMID: 38942806.
52. McKay SC, Louie BE, Molena D, Andrews WG, Boerner T, Hofstetter WL, Yeung J, Darling GE, Sharata A, Peyre CG, Dunn C, Lipham JC, Marginean H, DeMeester SR. Tumor Differentiation Impacts Response to Neoadjuvant Therapy and Survival in Patients With Esophageal Adenocarcinoma. J. Thorac Cardiovasc Surg 167(6):1943-1950, 2024. e-Pub 2023. PMID: 37788787.
53. Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances In Diagnosis And Management of Cancer of The Esophagus 385:e074962, 2024. e-Pub 2024. PMID: 38830686.
54. Deboever N, Feldman H, Eisenberg M, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Octreotide's Role in the Management of Post-esophagectomy Chylothorax. Dis Esophagus 37(6):doae011, 2024. e-Pub 2024. PMID: 38391198.
55. Eisenberg M, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Pulmonary Surgical Margins for Metastatic Osteosarcome: Is Negative Margin Enough?. e-Pub 2024. PMID: 38839026.
56. Ohannesian N, Mallick MS, He J, Qiao Y, Li N, Ahaitelman SF, Tang C, Shinn EH, Hofstetter WL, Goltsov A, Hassan MM, Hunt KK, Lin SH, Shih WC. Plasmonic Nano-aperture Label-free Imaging of Single Small Extracellular Vesicles For Cancer Detection. Comm Med (Lond), 2024. e-Pub 2024. PMID: 38796534.
57. Eisenberg MA, Deboever N, Mills AC, Egyud MR, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB. Impact of Travel Distance on Receipt of Indicated Adjuvant Therapy in Resected Non-Small Cell Lung Cancer. J Thorac Cardiovasc Surg 167(5):1617-1627, 2024. e-Pub 2023. PMID: 37696428.
58. Sewastjanow-Silva, M, Xiao, L, Nogueras Gonzalez, G, Wang, X, Hofstetter, WL, Swisher, SG, Mehran, RJ, Sepesi, B, Bhutani, M, Weston, B, Coronel, E, Waters, R, Rogers, JE, Smith, J, Lyons, L, Reilly, N, Yao, JC, Ajani, JA, Blum Murphy, M. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas. Cancers 16(7), 2024. e-Pub 2024. PMID: 38611056.
59. Feldman H, Sepesi B, Leung CH, Lin H, Weissferdt A, Pataer A, Jr WW, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone T. Surgical Outcomes After Chemotherapy Plus Nivolumab and Chemotherapy Plus Nivolumab and Ipilimumab in Patients with Non-Small Cell Lung Cancer. J Thorac Cardiovasc Surg 167(4):1444-1453, 2024. e-Pub 2023. PMID: 37816395.
60. Hofstetter WL. The IASLC Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor after Resection for the Forthcoming (9th) Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. e-Pub 2024. PMID: 38569931.
61. Hofstetter WL, Abana CO, Damen RJ, van Rossum PS, Bravo PL, Wei X, Pollard-Larken JM, Nitsch PL, Murphy MB, Hofstetter WL, Liao Z, Lin SH. Esophageal Cancer Outcomes After Definitive Chemotherapy With Intensity Modulated Proton Therapy. Int J Part Ther. e-Pub 2024. PMID: 38757074.
62. Damen PJJ, van Rossum PSN, Chen Y, Abana CO, Liao Z, Hobbs BP, Mohan R, Blum-Murphy M, Hofstetter WL, Lin SH. Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer. Int J Part Ther. e-Pub 2024. PMID: 38757081.
63. Damen, PJ, van Rossum, P, Chen, Y, Abana, CO, Liao, Z, Hobbs, BP, Mohan, R, Blum Murphy, M, Hofstetter, WL, Lin, SH. Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer. International Journal of Particle Therapy 11, 2024. e-Pub 2024. PMID: 38757082.
64. Abana, CO, Damen, PJ, van Rossum, P, Bravo, PL, Wei, X, Pollard-Larkin, JM, Nitsch, PL, Murphy, MB, Hofstetter, WL, Liao, Z, Lin, SH. Esophageal Cancer Outcomes After Definitive Chemotherapy With Intensity Modulated Proton Therapy. International Journal of Particle Therapy 11, 2024. e-Pub 2024. PMID: 38757075.
65. Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Lung Surveillance Following colorectal Cancer Pulmonary Metastasectomy: Utilization of Clinicopathologic Risk Factors To Guide Strategy. J Thorac Cardiovasc Surg, 2024. e-Pub 2023. PMID: 37495170.
66. Hofstetter WL. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study 16(7):1378, 2024. e-Pub 2024. PMID: 38611056.
67. Hofstetter WL. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the 'T' Descriptors in the Forthcoming 9th Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. e-Pub 2024. PMID: 38521202.
68. Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg 117(2):320-326, 2024. e-Pub 2024. PMID: 37080372.
69. Deboever N, Eisenberg MA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Perspectives, Risk Factors, and Coping Mechanisms in Patients With Self-Reported Financial Burden Following Lung Cancer Surgery. J Thorac Cardiovasc Surg 167(2):478-487, 2024. e-Pub 2024. PMID: 37356476.
70. Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Wash GL, Bednarski BK, Morris VK, Antonoff MB. Do Resected Colorectal Cancer Patients Need Early Chest Imaging? Impact of Clinicopathologic Characteristrics on Time To Development of Pulmonary Metastases. J Surg Oncolo 129(2):331-337, 2024. e-Pub 2024. PMID: 37876311.
71. Deboever N, Correa A, Feldman H, Mathur U, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB, Rajaram R. Disparities In Early-Stage Lung Cancer Outcomes At Minority Serving Hospitals Compared To Non-Minority Serving Hospitals. J Thorac Cardiovasc Surg 167(1):329-337, 2024. e-Pub 2024. PMID: 37116780.
72. Worrell SG, Goodman KA, Altorki NK, Ashman JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL, Hong TS, Kissoon K, Ku GY, Molena D, Tepper JE, Watson TJ, Williams T, Willett C. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Pract Radiat Oncol 14(1):28-46, 2024. e-Pub 2024. PMID: 37921736.
73. Worrell SG, Goodman KA, Altorki NK, Ashman JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL, Hong TS, Kissoon K, Ku GY, Molena D, Tepper JE, Watson TJ, Williams T, Willett C. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Ann Thorac Surg 117(1):15-32, 2024. e-Pub 2024. PMID: 37921794.
74. Shargall Y, Wiercioch W, Brunelli A, Murthy S, |Hofstetter WL, Lin J, Li H, Linkins LA, Crowther M, Davis R, Rocco G, Morgano GP, Schunemann F, Muti-Schunemann G, Douketis J, Schunemann HJ, Litle VR. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery Guidelines For The Prevention of Cancer-associated Venous Thromboembolism in Thoracic Surgery. Eur J Cardiothorac Surg 63(1):exac488, 2023. e-Pub 2023. PMID: 36519935.
75. Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rajaram R. Financial Toxicity in Patients With Resected Lung Cancer. Ann Surg 278(6):1038-1044, 2023. e-Pub 2023. PMID: 37249193.
76. Chidambaram S, Owen R, Sgromo B, Chmura M, Kisiel A, Evans R, Griffiths EA, Castoro C, Gronnier C, MaoAwyes MA, Gutschow CA, Piessen G, Degisors S, Alvieri R, Feldman H, Capovilla G, Grimminger PP, Han S, Low DE, Moore J, Gossage J, Voeten D, Gisbertz SS, Ruurda J, van Hillegersberg R, D'Journo XB, Chmelo J, Phillips AW, Rosati R, Hanna GB, Maynard N, Hofstetter W, Ferri L, Berge Henegouwen MI, Markar SR. Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study. Ann Surg. e-Pub 2023. PMID: 37477039.
77. McKay SC, Louie BE, Molena D, Andres WG, Boerner T, Hofstetter WL, Yeung J, Darling GE, Sharata A, Peyre CG, Dunn C, Lipham JC, Marginean H, DeMesster SR. Tumor Differentation Impacts Response to Neoadjuvant Therapy and Survival in Patients With Esophageal Adenocarcinoma. J Thorac Cardiovasc Surg. e-Pub 2023. PMID: 3778878.
78. Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyann AA, Walsh GL, Antonoff MB. Circulomic Variables Predict Pathologic Staging Preoperatively In Treatment-naive Non-small Cell Lung Cancer. J Thorac Dis 15(10):5507-5516, 2023. e-Pub 2023. PMID: 37969292.
79. Eisenberg MA, Hofstetter WL. Commentary: Complexity In Rare Disease: A Look At Surgical Outcomes In Tracheobronchial Adenoid Cystic Carcinoma. J Thorac Cardiovasc Surg 165(6):1965-1966, 2023. e-Pub 2023. PMID: 36609126.
80. Asamura H, Nishimura KK, Giroux DJ, Chansky K, Hoering A, Rusch V, Rami-Porta R, Hofstetter WL, IASLC Staging MOT, Committee PF, Advisory Boards OT, Institutions AP. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol 18(5):564-575, 2023. e-Pub 2023. PMID: 36773775.
81. Nelson DB, Mehran RJ, Mena GE, Hofstetter WL, Vaporciyan AA, Antonoff MB, Rice DC. Enhanced Recovery After Surgery Improves Postdischarge Recovery After Pulmonary Lobectomy. J Thorac Cardiovasc Surg 165(5):1731-1740, 2023. e-Pub 2023. PMID: 36404141.
82. Bayley EM, Ivy ML, Shewale JB, Ge PS, Antonoff MB, Francis AM, Hofstetter WL, Mehran RJ Rajaram R, Rice DC, Roth JA, Sepesi B, Vaporciyan AA, Walsh GL, Lee JJ, Louie BE, Swisher SG. High-Risk Features of Esophageal adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for whom Surgery Should Not Be Delayed. Ann Surg 277(5):721-726, 2023. e-Pub 2023. PMID: 36052678.
83. Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, IIson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, MukherjeeS, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LA. Esophageal and Esophagagastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21(4):393-422, 2023. e-Pub 2023. PMID: 37015332.
84. De Silva Sewastjanow M, Rogers JE, Hofstetter WL, Ajani JA. Esophageal Cancer: Is the CROSS Strategy Ready For History Books?. J Thorac Cardiovasc Surg 165(3):901-905, 2023. e-Pub 2023. PMID: 35184889.
85. Cascone T, Leung CH, Weisferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, Jr WW, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Jr BG, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG, Vaporciyan AA, Hy L, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi B. Neoadjuvant Chemotherapy Plus Nivolumab With or Without Ipilimumab in Operable Non-small Cell Lung Cancer: The Phase 2 Platform NEOSTAR Trial. Nat Med 29(3):593-604, 2023. e-Pub 2023. PMID: 36928818.
86. Shargall Y, Wiercioch W, Brunellie A, Murthy S, Hofstetter WL, Li H, Linkins LA, Crowther M, Davis R, Rocco G, Morgano GP, Schunemann F, Muti-Schunemann G, Douketis J, Schunemann HJ, Litle VR. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery Guidelines For The Prevention of Cancer-associated Venous Thromboembolism in Thoracic Surgery. J Thorac Cardiovasc Surg 165(3):794-824, 2023. e-Pub 2023. PMID: 36895083.
87. Deboever N, Hofstetter WL. From NLR to TIN: What Can't Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer?. Ann Surg Oncol 30(3):1295-1296, 2023. e-Pub 2023. PMID: 36607524.
88. Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Gruggs L, Vaporciyan A, Hofstetter WL, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NL. Clinical Outcomes of Combined Cervical and Transthoracic Surgical Approaches In Patients With Advanced Thyroid Cancer. Head Neck 45(3):547-554, 2023. e-Pub 2023. PMID: 36524701.
89. Mills AC, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi, B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Repeat Pulmonary Metastasectomy: Third Operations and Beyond. Ann Thorac Surg 115(3):679-685, 2023. e-Pub 2023. PMID: 35926641.
90. Vassilaopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Jr MA, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter WL, Nguyen QN, Badgewell BS, Ajani JA. Localized Gastroesophageal AdenocarcinomaIn The Elderly: Is Age A Factor Associated With Suboptimal Treatment?. Oncology 101(3):153-158, 2023. e-Pub 2023. PMID: 36412619.
91. Zhou N, Niu J, Nelson D, Feldman HA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Gl W, Giordano SH, Rajaram R. Surgical Approach and Persistent Opiod Use in Medicare Patients Undergoing Lung Cancer Resection. Ann thorac Surg. e-Pub 2023. PMID: 36801207.
92. Deboever N, Zhou N, McGrail DJ, Tomczak K, Oliva JL, Feldman HA, Parra E, Zhang J, Lee PP, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Swisher SS, Vaporciyan AA, Altan M, Weissferdt A, Tsao AS, Haymaker CL, Sepesi B. Radiographic Response to Neoadjuvant Therapy in Pleural Mesothelioma Should Serve as a Guide for Patient Selection for Cytoreductive Operations. Front Oncol 13, 2023. e-Pub 2023. PMID: 37637041.
93. Betancourt Cuellar SL, Benveniste MF, Truong M, Nguyen QN, Atiyah A, Hofstetter WL, Erasmus JJ. Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns. Am J Clin Oncol 46(1):25-30, 2023. e-Pub 2023. PMID: 36562692.
94. Deboever N, WL <. From NLR to TIN: What Can't Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer?. An Surg Oncol. e-Pub 2023. PMID: 36607524.
95. Zhou N, Hofstetter WL, Working Group ESCC, Mitchell KG, Bayley EM, Ajani JA, Antonoff MB, Betancourt SL, Blum-Murphy M, Feldman HA, Lin SH, Maru DM, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Weston BR. Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers. Ann Thorac Surg 114(6):2032-2040, 2022. e-Pub 2022. PMID: 34883083.
96. Zhou N, Bell CS, Feldman HA, Haymaker CL, Hofstetter WL, Tsao AS, Mehran RJ, Rice DC, Sepesi B, Genomic Group MI. Tumor Thickness In Mesothelioma Predicts Differential Response To Neoadjuvant Therapy And Survival. J Thorac Cardiovasc Surg. e-Pub 2022. PMID: 36737380.
97. Erwin PA, Lee AC, Ahmad U, Antonoff M, Arndt A, Backhus L, Berry M, Birdas T, Cassivi SD, Chang AC, Cooke DT, Crabtree T, DeCamp M, Donington J, Fernandez F, Force S, Gaissert H, Hofstetter W, Huang J, Kent M, Kim AW, Lin J, Martin LW, Meyerson S, Mitchell JD, Molena D, Odell D, Onaitis M, Puri V, Putnam JB, Reddy R, Schipper P, Seder CW, Shrager J, Tong B, Veeramachaneni N, Watson T, Whyte R, Ferguson MK. Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. Ann Thorac Surg 114(5):1895-1901, 2022. e-Pub 2022. PMID: 34688617.
98. Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi M, Stroehlein JR, Mehran RJ, Walsh G, Vaporciyan AA, Swisher SG, Hofstetter WL. Endoscopic Intrapyloric Botulinum Toxin Injection With Pyloric Balloon Dilation For Symptoms of Delayed Gastric Emptying After Distal Esophagectomy For Esophageal Cancer: A 10-Year Experience. Cancers (Basel) 14(23):5743, 2022. e-Pub 2022. PMID: 36497224.
99. Cools-Lartigue J, Markar S, Mueller C, Hofstetter W, Nilsson M, Ilonen I, Soderstrom H, Rasanen J, Gisbertz S, Hanna GB, Elliott J, Reynolds J, Kisiel A, Griffiths E, Van Berge Henegouwen M, Ferri L. An International Cohort Study of Prognosis Associated with Pathologically Complete Response Following Neoadjuvant Chemotherapy versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma. Ann Surg 276(5):799-805, 2022. e-Pub 2022. PMID: 35861351.
100. Sepesi B, Zhou N, William WN, Lin HY, Leung CH, Weissferdt A, Mitchell KG, Pataer A, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Negrao MV, Tsao AS, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone T. Surgical Outcomes After Nivolumab or Nivolumab With Ipilimumab Treatment In Patients With Non-small Cell Lung Cancer. J Thorac Cardiovasc Surg 164(5):1327-1337, 2022. e-Pub 2022. PMID: 35190177.
101. Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DX, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt SL. Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients. Ann Thorac Surg 114(4):1183-1188, 2022. e-Pub 2022. PMID: 34634240.
102. Feldman HA, Zhoud N, Deboever N, Hofstetter WL, Mehran R, Rajaram R, Rice D, Roth JA, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Godoy M, Strange C, Antonoff MB. Intraoperative Challenges After Induction Therapy for Non-small Cell Lung Cancer: Effect of Nodal disease on Technical Complexity. J Thorac Cardiovasc Surg 12:372-384, 2022. e-Pub 2022. PMID: 36590745.
103. Deboever N, Feldman HA, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era. J Surg Res 277:125-130, 2022. e-Pub 2022. PMID: 35489217.
104. Zhou N, Lee KH, Pedroza C, Hofstetter WL. Bayesian Post-hoc Analysis Of Chemoradiation With And Without Surgery In Patients With Locally Advanced Squamous Cell Carcinoma Of The Esophagus. J Thorac Cardiovasc Surg 164(3):688-693, 2022. e-Pub 2022. PMID: 34933771.
105. Pieretti AC, Ozambela M, Westerman ME, Nogueras-Gonzalez GM, Segarra LA, Zacharias NM, Vaporciyan A, Hofstetter W, Huynh T, Aldousari S, Matin SF, Karam JA. Predictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus. Clin Genitourin Cancer 20(4):e330-e338, 2022. e-Pub 2022. PMID: 35279419.
106. Zorrilla-Vaca A, Feldman H, Antonoff M, Sepesi B, Hofstetter W, Rajaram R, Swisher S, Mena G, Vaporciya A, Mehran R, Rice D. Single Chest Drain Practice Reduces Discharge Opioid Prescriptions in Thoracic Surgery. Thorac Cardiovasc Surg 70(5):422-429, 2022. e-Pub 2022. PMID: 34894636.
107. Bayley EM, Zhou N, Mitchell KG, Antonoff MB, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Cinciripini PM, Karam-Hage M, Roth JA, Hofstetter WL. Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients. Ann Thorac Surg 114(1):286-292, 2022. e-Pub 2022. PMID: 34358522.
108. Khaitan PG, Holliday T, Carroll A, Hofstetter WL, Bayley EM, Zhou N, Desale S, Watson TJ. Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?. J Gastrointest Surg 26(7):1345-1351, 2022. e-Pub 2022. PMID: 35414141.
109. Ruffini E, Rami-Porta R, Huang J, Ahmad U, Appel S, Bille A, Boubia S, Brambilla C, Cangir AK, Cilento V, Detterbeck F, Falkson C, Fang W, Filosso PL, Giaccone G, Girard N, Guerrera F, Infante M, Kim DK, Lucchi M, Marino M, Marom EM, Nicolson AG, Okumura M, Rimner A, CBnd S, Asamura H, Hofstetter WL. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues To Be Addressed For The Next Ninth Edition Of The TNM Classification of Malignant Tumors. J Thorac Oncol 17(6):838-851, 2022. e-Pub 2022. PMID: 35321838.
110. Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Strange CD, Antonoff MB. Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer. Ann Thorac Surg 113(6):1835-1844, 2022. e-Pub 2022. PMID: 34252403.
111. Kamarajah SK, Griffiths EA, Phillips AW, Ruurda J, van Hillegersberg R, Hofstetter WL, Markar SR. ASO Visual Abstract: Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment Of Short And Long-Term Clinical Outcomes. Ann Surg Oncol 29(5):2828-2829, 2022. e-Pub 2022. PMID: 35022904.
112. Kamarajah SK, Griffiths EA, Phillips AW, Ruurda J, van Hillegersberg R, Hofstetter WL, Markar SR. Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short-and Long-Term Clinical Outcomes. Ann Surg Oncol 29(5):2812-2825, 2022. e-Pub 2022. PMID: 34890023.
113. Kamarajah SK, Griffiths EA, Phillips AW, Ruurda J, van Hillegersberg R, Hofstetter WL, Markar SR. ASO Author Reflections: Modern-Day Implementations of Robotic Esophagogastric Cancer Surgery. Ann Surg Oncol 29(5):2826-2827, 2022. e-Pub 2022. PMID: 34839424.
114. Bostock IC, Zhou N, Antonoff MB, Murphy MB, Lin S, Maru D, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Prolonged Neutrophilia Is Associated With Worse Outcomes After Esophagectomy. Dis Esophagus 35(4):doab081, 2022. e-Pub 2022. PMID: 34897440.
115. Khaitan PG, Holliday T, Carroll A, Hofstetter WL, Bayley EM, Zhou N, Desale S, Watson TJ. Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?. J Gastrointest Surg. e-Pub 2022. PMID: 35414141.
116. Schaverien MV, Hofstetter WL, Hall MS, Chen DN, Selber JC. Jejunal Mesenteric Vascularized Lymph Node Transplantation for Lymphedema: Outcomes and Techmical Modifications. Plast Reconstr Surg 149(4):700e-710e, 2022. e-Pub 2022. PMID: 35157612.
117. Zhao H, Misariu AM, Ramirez-GarciaLuna JL, Nobel T, Mueller C, Cools-Lartigue J, Spicer J, Molena D, Bains M, Swisher S, Hofstetter W, Ferri L. Synchronous Esophageal and Lung Cancers - Is Combined anatomic Resection Appropriate?. Ann Thorac Surg 113(4):1354-1360, 2022. e-Pub 2022. PMID: 33905733.
118. van der Wilk BJ, Eyck BM, Hofstetter WL, Ajani JA, Piessen G, Castoro C, Alfieri R, Kim JH, Kim SB, Furlong H, Walsh TN, Nieboer D, Wijnhoven BPL, Lagarde SM, JJBV L. Chemoradiotherapy followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis. Ann Surg 275(3):467-476, 2022. e-Pub 2022. PMID: 34191461.
119. Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg 113(3):975-983, 2022. e-Pub 2022. PMID: 33838123.
120. Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small cell Lung Cancer. Ann Thorac Surg 113(3):1008-1014, 2022. e-Pub 2022. PMID: 33774003.
121. Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AA. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep 3(3):100288, 2022. e-Pub 2022. PMID: 35252897.
122. Zorrilla-Vaca A, Rice D, Brown JK, Antonoff M, Sepesi B, Hofstetter W, Swisher S, Walsh G, Vaporciyan A, Mehran R, Hagberg C, Mena GE. Sustained Reduction of Discharge Opioid Prescriptions In An Enhanced Recovery After Thoracic Surgery Program: A Multilevel Generalized Linear Model. Surgery 1(2):504-510, 2022. e-Pub 2022. PMID: 34740455.
123. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(2):167-192, 2022. e-Pub 2022. PMID: 35130500.
124. van der Wil BJ, Hagens ERC, Eyck BM, Gisbertz SS, van Hillegersberg R, Nafteux P Schroder W, Nilsson M, Wijnhoven BPL, Lagarde SM, van Berge Henegouwen MI, Hofstetter WL, Group Collaborators IES. Outcomes After Totally Minimally Invasive Versus Hybrid And Open Ivor Lewis Oesphagectomy Results From The International Esodata Study Group. Br J Surg 109(33):283-290, 2022. e-Pub 2022. PMID: 35024794.
125. Deboever N, McGrail DJ, Lee Y, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Bernatchez C, Vailati Negrao M, Zhang J, Wistuba II, Heymach JV, Cascone T, Gibbons DL, Haymaker CL, Sepesi B. Surgical Approach Does Not Influence Changes In Circulating Immune Cell Populations Following Lung Cancer Resection. Lung Cancer 164:69-75, 2022. e-Pub 2022. PMID: 35038676.
126. Saddoughi SA, Mitchell KG, Antonoff MB, Fruth KM, Taswell J, Mounajjed T, Hofstetter WL, Rice DC, Shen KR, Blackmon SH. Analysis of Esophagectomy Margin Practice and Survival Implications. Ann Thorac Surg 113(1):209-216, 2022. e-Pub 2022. PMID: 33524359.
127. Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi B. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg 113(1):200-208, 2022. e-Pub 2022. PMID: 33971174.
128. Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JA. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut 70(12):2238-2248, 2021. e-Pub 2021. PMID: 33487592.
129. Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff MB. Barriers To Surveillance Imaging Adherence In Early-Staged Lung Cancer. J Thorac Dis 13(12):6848-6854, 2021. e-Pub 2021. PMID: 35070369.
130. Rice D, Rodriguez-Restrepo A, Mena G, Cata J, Thall P, Milton D, Correa A, Woodard T, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Mehran R. Matched Pairs Comparison of an Enhanced Recover Pathway Versus Conventional Management on Opioid exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg 274(6):1099-1106, 2021. e-Pub 2021. PMID: 32229762.
131. Kamarajah SK, Phillips AW, Griffiths EA, Ferri L, Hofstetter WL, Markar SR. Esophagectomy or Total Gastrectomy for Siewert 2 Gastroespohageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis. Ann Surg Oncol 28(13):8485-8494, 2021. e-Pub 2021. PMID: 34255246.
132. Kamarajah SK, Phillips AW, Griffiths EA, Ferri L, Hofstetter WL, Markar SR. ASO Visual Abstract: Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis. Ann Surg Oncol Suppl 3:517-518, 2021. e-Pub 2021. PMID: 34241749.
133. Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Working Group EA, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. Esophageal Adenocarcinoma With Any Component of Signet Rig Cells Portends Poor Prognosis and Response to Neoadjuvant Therapy. J Thorac Cardiovasc Surg 162(5):1404-1412.e2, 2021. e-Pub 2021. PMID: 33010880.
134. Blumenthaler AN, Zhou N, Parikh K, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients. Innovations (Phila) 16(6):529-535, 2021. e-Pub 2021. PMID: 34494925.
135. Chang, JY, Mehran, RJ, Feng, L, Verma, V, Liao, Z, Welsh, J, Lin, SH, O'Reilly, M, Jeter, M, Balter, PA, McRae, SE, Berry, D, Heymach, JV, Roth, JA, Antonoff, MB, Hofstetter, WL, Rajaram, R, Rice, DC, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL, DeGraaf, C, Correa, AM, Chen, A, Gandhi, S, Komaki, R, Lee, PP, Nguyen, Q, Ning, M, Gao, S, Pollard-Larkin, JM, Nitsch, PL, Sadagopan, R, Wang, X. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS). The lancet oncology 22(10):1448-1457, 2021. e-Pub 2021. PMID: 34529930.
136. Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SL. Clinical Significance of FDG-PET/CT Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients. Ann Thorac Surg. e-Pub 2021. PMID: 34634240.
137. Chang JY, Mehan RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA, Hofstetter WL, Trials Group SLC. Stereotactic Ablative Radiotherapy For Operable Stage I Non-small Cell Lung Cancer (Revised STARS): Long-term Results Of A Single-Arm, Prospective Trial With Prespecified Comparison To Surgery. Lancet Oncol 22(10):1448-1457, 2021. e-Pub 2021.
138. Zhou N, Mitchell KG, Corsini EM, Truong VTT, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WL. Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma. Br J Surg 108(10):1207-1215, 2021. e-Pub 2021. PMID: 34095952.
139. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy. J Gastrointest Surg 25(9):2185-2191, 2021. e-Pub 2021. PMID: 33555525.
140. D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schröder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE, Study Group IE. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg 156(9):836-845, 2021. e-Pub 2021. PMID: 34160587.
141. Corsini EM, Mitchell KG, Zhou N, Bernatchez C, Forget MA, Haymaker CL, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Amaria RN, Jazaeri AA, Antonoff MB. Pulmonary Resection For Tissue Harvest In Adoptive Tumor-infiltrating Lymphocyte Therapy: Safety and Feasibility. J Surg Oncol 124(4):699-703, 2021. e-Pub 2021. PMID: 34057733.
142. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Mena GE, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Hofstetter WL. Liposomal Bupivacaine Intercostal Block is Important for Reduction of Pulmonary Complications. Ann Thorac Surg 112(23):423-429, 2021. e-Pub 2021. PMID: 33129774.
143. Bryan DS, Ferguson MK, Antonoff MB, Backhus LM, Birdas TJ, Blackmon SH, Boffa DJ, Chang AC, Chmielewski GW, Cooke DT, Donington JS, Gaissert HA, Hagen JA, Hofstetter WL, Kent MS, Kim KW, Krantz SB, Lin J, Martin LW, Meyerson SL, Mitchell JD, Molena D, Odell DD, Onaitis MW, Puri V, Putnam JB, Seder CW, Shrager JB, Soukiasian HJ, Stiles BM, Tong BC, Veeramachaneni NK. Consensus For Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg 112(2):436-442, 2021. e-Pub 2021. PMID: 33127408.
144. Corsini EM, Mitchell KG, Correa A, Morris VK Antonoff MB, Hofstetter W, Group MD. Effect of Primary Colorectal Cancer Tumor Location on Survival After Pulmonary Metastasectomy. J Thorac Cardiovasc Surg 162(1):296-305, 2021. e-Pub 2021. PMID: 32713636.
145. Feldman HA, Zhou N, Antonoff MB, Hofstetter WL, Rajaram R, Rice DC, Sepesi B, Vaporciyan AA, Zorrilla-Vaca A, Mehran RJ. Simultaneous Versus Staged Resections for Bilateral Pulmonary Metastases. J Surg Oncol 123(7):1633-1639, 2021. e-Pub 2021. PMID: 33684226.
146. Müller PC, Kapp JR, Vetter D, Bonavina L, Brown W, Castro S, Cheong E, Darling GE, Egberts J, Ferri L, Gisbertz SS, Gockel I, Grimminger PP, Hofstetter WL, Hölscher AH, Low DE, Luyer M, Markar SR, Mönig SP, Moorthy K, Morse CR, Müller-Stich BP, Nafteux P, Nieponice A, Nieuwenhuijzen GAP, Nilsson M, Palanivelu C, Pattyn P, Pera M, Räsänen J, Ribeiro U, Rosman C, Schröder W, Sgromo B, van Berge Henegouwen MI, van Hillegersberg R, van Veer H, van Workum F, Watson DI, Wijnhoven BPL, Gutschow CA. Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus. Dis Esophagus 34(6), 2021. e-Pub 2021. PMID: 32960264.
147. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Lin SH, Ajani JA, Hofstetter WL. Modified En bloc Esophagectomy Compared to Standard Resection after Neoadjuvant Chemoradiation. Ann Thorac Surg 111(33):1133-1140, 2021. e-Pub 2021. PMID: 32857997.
148. Corsini EM, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac. Ann Thorac Surg 111(45):1111-1117, 2021. e-Pub 2021. PMID: 32980327.
149. Kamarajah SK, Phillips AW, Ferri L, Hofstetter WL, Markar SR. Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study. Br J Surg 108(4):403-411, 2021. e-Pub 2021. PMID: 33755097.
150. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases In Resectable Esophageal Or Gastroesophageal Junction Adenocarcinoma. Ann Surg 273(4):751-757, 2021. e-Pub 2021. PMID: 31188215.
151. Cascone T, William WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med 27(3):504-514, 2021. e-Pub 2021. PMID: 33603241.
152. Hofstetter WL. Discussion. J Thorac Cardiovasc Surg 161(3):842-843, 2021. e-Pub 2021. PMID: 33485656.
153. Zhou N, Bott M, Park BJ, Vallieres E, Wilshire CL, Yasufuku K, spicer JD, Jones DR, Sepesi B, Hofstetter WL, working Group SCLC. Predictors of Survival Following Surgical Resection of Limited-stage Small Cell Lung Cancer. J Thorac Cardiovasc Surg 161(3):760-771, 2021. e-Pub 2021. PMID: 33349449.
154. Betancourt-Cuellar SL, Benveniste MFK, Palacio DP, Hofstetter WL. Esophageal Cancer: Tumor-Node-Metastasis Staging. Radiol Clin North Am 59(2):219-229, 2021. e-Pub 2021. PMID: 33551083.
155. Corsini EM, Hofstetter WL, Group MD. Ketorolac Use and Anastomotic Leak in Patients With Esophageal Cancer. J Thorac Cardiovasc Surg 161(2nd):448-454, 2021. e-Pub 2021. PMID: 32340809.
156. Parra ER, Zhai J, Tamegnon A, Zhou N, Pandurengan RK, Barreto C, Jiang M, Rice DC, Creasy C, Vaporciyan AA, Hofstetter WL, Tsao AS, Wistuba II, Sepesi B, Haymaker C. Identification of Distinct Immune Landscapes Using An Automated Nine-Color Multiplex Immunofluorescense Staining Panel and Image analysis in Paraffin Tumor Tissues. Sci Rep 11(1):4530, 2021. e-Pub 2021. PMID: 33633208.
157. Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Pathological Nodal Disease Defines Survival Outcomes in Patients With Lung Cancer With Tumour Major Pathological Response Following Neoadjuvant Chemotherapy. Eur J Cardiothorac Surg 59(1):100-108, 2021. e-Pub 2021. PMID: 32864702.
158. Gironda DJ, Adams DL, He J, Xu T, Gao H, Qiao Y, Komaki R, Reuben JM, Liao Z, Blum-Murphy M, Hofstetter WL, Tang CM, Lin SH. Cancer Associated Macrophage-like Cells and Prognosis of Esophageal Cancer after Chemoradiation Therapy. J Transl Med 18(1):413, 2020. e-Pub 2020. PMID: 33148307.
159. Kim BJ, Chiang YJ, Das P, Minsky BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CD, Badgwell BD, Mansfield PF, Ikoma N. Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. J Clin Med 9(11):3495, 2020. e-Pub 2020. PMID: 33138060.
160. Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rice DC. Importance of Resection For Locoregional Disease Control in Masaoka Stage IVA Thymic Neoplasms. J Surg Oncol 122(3):515-522, 2020. e-Pub 2020. PMID: 32468580.
161. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain Metastases in Patients With Upper Gastrointestinal Cancer is Associated with Proximally Located Adenocarcinoma and Lymph Node Metastases. Gastric Cancer 23(5):904-912, 2020. e-Pub 2020. PMID: 32347396.
162. Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi B. Time Trends and Predictors of Survival in Surgically Resected Early-Stage Non-Small Cell Lung Cancer Patients. J Surg Oncol 122(3):495-505, 2020. e-Pub 2020. PMID: 32356321.
163. Corsini EM, Wang Q, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Reuben A, Vasquez ME, Bernatchez C, Wang J, Cascone T, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi B. Peripheral Cytokines Are Not Influenced By The Type of Surgical Approach For Non-small Cell Lung Cancer By Four Weeks Postoperatively. Lung Cancer 146:303-309, 2020. e-Pub 2020. PMID: 32619781.
164. Hofstetter WL. ISDE Presidential Bio; Tom R DeMeester, Fourth President of the ISDE. Dis Esophagus 33(8), 2020. e-Pub 2020. PMID: 32744325.
165. Brigger D, Riether C, van Brummelen R, Mosher KI, Shiu A, Ding Z, Zbären N, Gasser P, Guntern P, Yousef H, Castellano JM, Storni F, Graff-Radford N, Britschgi M, Grandgirard D, Hinterbrandner M, Siegrist M, Moullan N, Hofstetter W, Leib SL, Villiger PM, Auwerx J, Villeda SA, Wyss-Coray T, Noti M, Eggel A. Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age. Nat Metab 2(8):688-702, 2020. e-Pub 2020. PMID: 32694825.
166. Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With A High Cure Rate Among Esohageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg 272(2):311-318, 2020. e-Pub 2020. PMID: 32675544.
167. Hofstetter W. Commentary: Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography For Cervical Adenopathy In Esophageal Carcinoma An Option For The Selective Surgeon. J Thorac Cardiovasc Surg 160(2):551-552, 2020. e-Pub 2020. PMID: 31955937.
168. Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone T. 18 F-Fuorodeoxyglucose Positron Emission Tomography Correlates with Tumor Immunometabolic Phenotypes in Resected Lung Cancer. Cancer Immunol Immunother 69(8):1519-1534, 2020. e-Pub 2020. PMID: 32300858.
169. Zafar SN, Blum M, Chiang YJ, Ajani JA, Estrella JS, Das P, Minsky BD, Hofstetter WL, Mansfield P, Badgwell BD, Ikoma N. Preopertive Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma. Ann Thorac Surg 110(2):398-405, 2020. e-Pub 2020. PMID: 32289300.
170. Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B. Locoregional Control, Overall Survival and Disease-Free Survival in Stage IIIA (n2) Non-Small-Cell Lung Cancer: Ananlysis of Resected and Unresected Patients. Clin Lung Cancer 21(4):e294-e301, 2020. e-Pub 2020. PMID: 32089476.
171. Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SG. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer 21(4):341-348, 2020. e-Pub 2020. PMID: 32279936.
172. Corkum JP, Garvey PB, Baumann DP, Abraham J, Liu J, Hofstetter W, Butler CE, Clemens MW. Reconstruction of Massive Chest Wall Defects: A 20-year Experience. J Plast Reconstr Aesthet Surg 73(6):1091-1098, 2020. e-Pub 2020. PMID: 32269009.
173. Hofstetter W. Commentary: Delayed Resection For Esophageal Adenocarcinoma. J Thorac Cardiovasc Surg 159(6):2568-2569, 2020. e-Pub 2020. PMID: 31926682.
174. Agzarian J, Litle V, Linkins LA, Brunelli A, Schneider L, Kestenholz P, Li H, Rocco G, Girard P, Nakajima J, Samama CM, Scarci M, Anraku M, Falcoz PE, Bertolaccini L, Lin J, Murthy S, Hofstetter W, Okumura M, Solli P, Minervini F, Kirk A, Douketis J, Shargall Y. International Delphi Survey Of The ESTS/AATS/ISTH Task Force On Venous Thromboembolism Prophylaxis In Thoracic Surgery: The Role Of Extended Post-Discharge Prophylaxis. Eur J Cardiothorac Surg 57(5):854-859, 2020. e-Pub 2020. PMID: 31769796.
175. Mitchell KG, Cuentas P, ER, Lee, IJ, Vaporciyan AA, Hofstetter WL, Mehran, RJ, Swisher SG, Rice DC, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran C, Skoulidis F, Wistuba II, Antonoff MB, Heymach JV. LKB1/STK11Expression in Lung Adenocarcinoma and Associations with Patterns of Recurrence. Ann Thorac Surg 110(4):1131-1138, 2020. e-Pub 2020. PMID: 32442617.
176. Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy For Locally Advanced Esophageal Cancer. J Clin Oncol 38(14):1569-1579, 2020. e-Pub 2020. PMID: 32160096.
177. Corsini EM, Datar SS, Mitchell KG, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Blackmon SH, Loree JM, Morris VK, Antonoff MB. High Mutational Concordance Between Primary Colorectal Tumors and Associated Pulmonary Metastases. J Surg Oncol 121(6):984-989, 2020. e-Pub 2020. PMID: 32077113.
178. Saulacic N, Muñoz F, Kobayashi E, Chappuis V, Gonzáles-Cantalapiedra A, Hofstetter W. Effects of local application of alendronate on early healing of extraction socket in dogs. Clin Oral Investig 24(4):1579-1589, 2020. e-Pub 2020. PMID: 31346723.
179. Konradsson M, van Berge Henegouwen MI, Bruns C, Chaudry MA, Cheong E, Cuesta MA, Darling GE, Gisbertz SS, Griffin SM, Gutschow CA, van Hillegersberg R, Hofstetter W, Hölscher AH, Kitagawa Y, van Lanschot JJB, Lindblad M, Ferri LE, Low DE, Luyer MDP, Ndegwa N, Mercer S, Moorthy K, Morse CR, Nafteux P, Nieuwehuijzen GAP, Pattyn P, Rosman C, Ruurda JP, Räsänen J, Schneider PM, Schröder W, Sgromo B, Van Veer H, Wijnhoven BPL, Nilsson M. Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process. Dis Esophagus 33(4), 2020. e-Pub 2020. PMID: 31608938.
180. Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus 33(3), 2020. e-Pub 2020. PMID: 31313820.
181. May RD, Frauchiger DA, Albers CE, Hofstetter W, Gantenbein B. Exogenous Stimulation of Human Intervertebral Disc Cells in 3-Dimensional Alginate Bead Culture With BMP2 and L51P: Cytocompatibility and Effects on Cell Phenotype. Neurospine 17(1):77-87, 2020. e-Pub 2020. PMID: 32252157.
182. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MB. Hospital Readmissions After Pulmonary Resection: Post-Discharge Nursing Telephone Assessment Identifies High Risk Patients. J Thorac Dis 12(3):184-190, 2020. e-Pub 2020. PMID: 32274083.
183. Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune Regulartory Markers of Lepidic-pattern Adenocarcinomas presenting as ground Glass Opacities. J Thorac Dis 12(3):329-337, 2020. e-Pub 2020. PMID: 32274099.
184. Edwards JG, Chansky K, Van Schill P, Nicholson AG, Boubia S, Brambilla E, Donington J, Galateau-Salle' F, Hoffmann H, Infante M, Marino M, Marom EM, Nakajima J, Ostrowski M, Travis WD, Tsao MS, Yatabe Y, Giroux DJ, Shemanski K, Crowley J, Krasnik M, Asamura H, Rami-Porta R, Hofstetter WL, Cancer Staging IAFTSOL, Committee PF, Members AB, Institutions P. The IASLC Lung Cancer staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer. J Thorac Oncol 15(3):344-359, 2020. e-Pub 2020. PMID: 31731014.
185. Hofstetter, WL. Commentary: Maximizing Response and Outcomes in Multimodality Therapy for Locally Advancedd Esophageal Adenocarcinoma. J Thorac Cardiovasc Surg 157(4):1694-1695, 2020. e-Pub 2020.
186. Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen Q, Ajani JA. Taxane-based or Platinum-based Combination Chemotherapy Given Concurrently With Radiation Followed By Surgery Resulting in High Cure Rates in Esophageal Cancer Patients. Medicine (Baltimore) 99(9):e19295, 2020. e-Pub 2020. PMID: 32118743.
187. Nelson DB, Niu J, Mitchell KG, Antonoff MB, Giordano SH, Hofstetter WL, Vaporciyan AA, Sepesi B, Mehran RJ, Rice DC. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Difference Between Men and Women. J Thorac Cardiovasc Surg 159(2):691-702, 2020. e-Pub 2020. PMID: 33003262.
188. Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B. Time Trends of Perioperative Outcomes in Early-Stage Non-Small Cell Lung Cancer Resection Patients. Ann Thorac Surg 109(2):404-411, 2020. e-Pub 2020. PMID: 31539514.
189. Shargall Y, Brunelli A, Murthy S, Schneider L, Minervini F, Bertolaccini L, Agzarian J, Linkins LA, Kestenholz P, Li H, Rocco G, Girard P, Venuta F, Samama M, Scarci M, Anraku M, Falcoz PE, Kirk A, Solli P, Hofstetter W, Okumura M, Douketis J, Litle V. Venous Thromboembolism Prophylaxis in Thoracic Surgery Patients: An International Survey. Eur J Cardiothorac Surg 57(2):331-337, 2020. e-Pub 2020. PMID: 31363740.
190. Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB. Surveillance After Treatment Of Non-Small-Cell Lung Cancer: A Call For Multidisciplinary Standardization. Innovations (Phila) 15(12):57-65, 2020. e-Pub 2020. PMID: 31875755.
191. Nelson DB, Niu J, Mitchell KG, Sepesi B, Hofstetter WL, Antonoff MB, Giordano SH, Mehran RJ, Rice DC. Persistant Opioid Use Among The Elderly After Lung Resection: A SEER-Medicare Study. Ann Thorac Surg 109(1):194-202, 2020. e-Pub 2020. PMID: 31445908.
192. Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin For Lung Cancer Resection Increases Risk Of Reoperation For Bleeding. Semin Thorac Cardiovasc Surg 32(2):337-343, 2020. e-Pub 2020. PMID: 31857153.
193. Veeranki OL, Tong Z, Mejia A, Verma A, Katkhuda R, Bassett R, Kim TB, Wang J, Lang W, Mino B, Solis L, Kingsley C, Norton W, Tailor R, Wu JY, Krishnan S, Lin SH, Blum M, Hofstetter W, Ajani J, Kopetz S, Maru D. A Novel Patient-Derived Orthotopic Xenograft Model Of Esophageal Adenocarcinoma Provides a Platform For Translational Discoveries. Dis Model Mech 12(12), 2019. e-Pub 2019. PMID: 31732509.
194. Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL. Should Endoscopic Mucosal Resection Be Attempted for cT2N0 Esophageal Cancer?. Dis Esophagus 32(10):1-6, 2019. e-Pub 2019. PMID: 30888418.
195. Hofstetter WL. Open Versus Hybrid Minimally Invasive Esophagectomy: Join The Crowd, But Do Not Throw Away Your Abdominal Retractors Just Yet. J Thorac Cardiovasc Surg 158(5):1475-1478, 2019. e-Pub 2019. PMID: 31623814.
196. Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol 5(11):1597-1604, 2019. e-Pub 2019. PMID: 31529018.
197. Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B. Tumor Characteristics Associated With Engraftment of Patient-Derived Non-small Cell Lung Cancer Xenografts in Immunocompromised Mice. Cancer 125(21):3738-3748, 2019. e-Pub 2019. PMID: 31287557.
198. Mays AC, Yu P, Hofstetter W, Liu J, Xue A, Klebuc M, Chevray P, Selber J. The Supercharged Pedicled Jejunal Flap (SPJ) for Total Esophageal Reconstruction: A Retrospective Review of 100 Cases. Plast Reconstr Surg 144(5):1171-1180, 2019. e-Pub 2019. PMID: 31441806.
199. Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DC. Persistent Opioid Use Is Associated with Worse Survival After Lobectomy for Stage I Non-small Cell Lung Cancer. Pain 160(10):2365-2373, 2019. e-Pub 2019. PMID: 31149979.
200. Nelson DB, Tayob N, Nguyen QN, Erasmus J, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJ. Local Failure After Stereotactic Body Radiation Therapy Or Wedge Resection For Colorectal Pulmonary Metastases. J Thorac Cardiovasc Surg 158(4):1234-1241, 2019. e-Pub 2019. PMID: 31395367.
201. Mitchell KG, Parra ER, Nelson DB, Zhang J, Wistuba II, Fugimoto J, Roth JA, Antonoff MB, Hofstetter WL. Tumor Cellular Proliferation is Associated With Enhanced Immune Checkpoint Expression in Stage I Non-small Cell Lung Cancer. J Thorac Cardiovasc Surg 158(3):911-919, 2019. e-Pub 2019. PMID: 31235357.
202. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation For Siewert II/III Adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
203. Semenkovich TR, Subramanian M, Yan Y, Hofstetter WL, Correa AM, Cassivi SD, Inra ML, Stiles BM, Altorki NK, Chang AC, Brescia AA, Darling GE, Allison F, Broderick SR, Etchill EW, Fernandez FG, Chihara RK, Litle VR, Muñoz-Largacha JA, Kozower BD, Puri V, Meyers BF. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study. Ann Thorac Surg 108(3):828-836, 2019. e-Pub 2019. PMID: 31229485.
204. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Colorectal Cancer Mutations Are Associated With Survival And Recurrence After Pulmonary Metastasectomy. J Surg Oncol 120(4):729-735, 2019. e-Pub 2019. PMID: 31290159.
205. Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC. Robotic Assisted Lobectomy For Non-Small Cell Lung Cancer. Ann Thorac Surg 108(2):370-376, 2019. e-Pub 2019. PMID: 31004583.
206. Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB. Multidisciplinary Treatment of Thymic Neuroendocrine Tumors: Surgery Remains a Key Component. J Thorac Dis 11(8):3391-3398, 2019. e-Pub 2019. PMID: 31559043.
207. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA. Esophageal and Esophagogasric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(7):855-883, 2019. e-Pub 2019. PMID: 31319389.
208. Veeranki OL, Tong Z, Dokey R, Mejia A, Zhang J, Qiao Y, Singh PK, Katkhuda R, Mino B, Tailor R, Canales JR, Bassett R, Ajani J, Wu JY, Kopetz S, Blum M, Hofstetter W, Tetzlaff M, Krishnan S, Lin SH, Maru D. Targeting Cyclin-Dependent Kinase 9 By A Novel Inhibiyor Enhances Radiosensitization and Identifies Axl As A Novel Downstream Target In Esophageal Adenocarcinoma. Oncotarget 10(45):4703-4718, 2019. e-Pub 2019. PMID: 31384397.
209. Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, JJGHM B, MCCM H, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS. Distribution of Lymph Node Metastases in Esophageal Carcinoma: Study Protocol of a Multinational Observational Study. BMC Cancer 19(1):662, 2019. e-Pub 2019. PMID: 31272485.
210. Zhao W, Michalik D, Ferguson S, Hofstetter W, Lemaître J, von Rechenberg B, Bowen P. Rapid evaluation of bioactive Ti-based surfaces using an in vitro titration method. Nat Commun 10(1):2062, 2019. e-Pub 2019. PMID: 31048680.
211. Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B. Defining The Role Of Adjuvant Radiotherapy For Malignant Pleural Mesothelioma; A Propensity-Matched Landmark Analysis Of the National Cancer Database. J Thorac Dis 11(4):1269-1278, 2019. e-Pub 2019. PMID: 31179069.
212. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical Margins and Risk Of Local Recurrence After Wedge Resection Of Colorectal Pulmonary Metastases. J Thorac Cardiovasc Surg 157(4):1648-1655, 2019. e-Pub 2019. PMID: 30635188.
213. Hofstetter WL. Commentary: Maximizing response and outcomes in multimodality therapy for locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg 157(4):1694-1695, 2019. e-Pub 2019. PMID: 30642620.
214. Xi M, Yang Y, Zhang L, Yang H, Merrell KW, Hallemeier CL, Shen RK, Haddock MG, Hofstetter WL, Maru DM, Ho L, Wu CC, Liu M, Lin SH. Multi-Institutional Analysis of Recurrence And Survival After Neoadjuvant Chemoradiotherapy Of Esophageal Cancer: Impact Of Histology On Recurrence Patterns And Outcomes. Ann Surg 269(4):663-670, 2019. e-Pub 2019. PMID: 29334555.
215. Gallo M, Le Gars Santoni B, Douillard T, Zhang F, Gremillard L, Dolder S, Hofstetter W, Meille S, Bohner M, Chevalier J, Tadier S. Effect of grain orientation and magnesium doping on β-tricalcium phosphate resorption behavior. Acta Biomater 89:391-402, 2019. e-Pub 2019. PMID: 30831328.
216. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing. Ann Thorac Surg 107(3):936-940, 2019. e-Pub 2019. PMID: 30612991.
217. Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, Davies A, D'Journo XB, Gisbertz SS, Griffin SM, Hardwick R, Hoelscher A, Hofstetter W, Jobe B, Kitagawa Y, Law S, Mariette C, Maynard N, Morse CR, Nafteux P, Pera M, Pramesh CS, Puig S, Reynolds JV, Schroeder W, Smithers M, Wijnhoven BPL. Benchmarking Complications Associated With Esophagectomy. Ann Surg 269(2):291-298, 2019. e-Pub 2019. PMID: 29206677.
218. Luo W, Hofstetter WL, Tan D. Gastroesophageal Junction Paneth Cell Carcinoma With Extensive Cystic and Secretory Features - Case Report and Literature Review. Diagn Pathol 14(1):1, 2019. e-Pub 2019. PMID: 30621725.
219. Irsigler B, Zheng JH, Hofstetter W. Interacting Hofstadter Interface. Phys Rev Lett 122(1):010406, 2019. e-Pub 2019. PMID: 31012663.
220. Tong Z, Mejia A, Veeranki O, Verma A, Correa AM, Dokey R, Patel V, Solis LM, Mino B, Kathkuda R, Rodriguez-Canales J, Lin SH, Krishnan S, Kopetz S, Blum M, Ajani JA, Hofstetter WL, Maru DM. Targeting CDK9 and MCL-1 By A New CDK9/p-TEFb Inhibitor With And Without 5-Fluorouracil In Esophageal Adenocarcinoma. Ther Adv Med Oncol 11:1758835919864850, 2019. e-Pub 2019. PMID: 31384313.
221. Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione Reductase (GSRGene Deletion and Chromosone 8 Aneuploidy in Primary Lung Cancers Detected by Fluorescence in Situ Hybridization. Am J Cancer Res 9(6):1201=1211, 2019. e-Pub 2019. PMID: 31285952.
222. Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Occult Stage IIIA-N2 Patients Have Excellent Overall Survival With Initial Surgery. J Thorac Dis 10(12):6670-6676, 2018. e-Pub 2018. PMID: 30746212.
223. Hofstetter WL. Maximizing Response and Outcomes In Multimodality Therapy For Locally Advanced Esophageal Adenocarcinoma. J Thorac Cardiovasc Surg. e-Pub 2018.
224. Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. Ann Thorac Surg 106(5):1499-1503, 2018. e-Pub 2018. PMID: 30118712.
225. Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD. Preoperative Chemoradiation Therapy Induces Primary-Tumor Complete Response More Frequently Than Chemothrapy Alone In Gastric Cancer: Analyses Of The National Cancer Database 2006-2014 Using Propensity Score Matching. Gastric Cancer 21(6):1004-1013, 2018. e-Pub 2018. PMID: 29730720.
226. Nelson DB, Tam AL, Mitchell KG, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Vaporciyan AA, Hofstetter WL. Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review. Ann Thorac Surg. e-Pub 2018. PMID: 30508527.
227. Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BD. Surgeon Assessment of Gasric Cancer Lymph Node Specimens With A Video of Technique. J Gastrointest Surg 22(11):2013-2019, 2018. e-Pub 2018. PMID: 30054780.
228. Goense L, Merrell KW, Arnett AL, Hallemeier CL, Meijer GJ, Ruurda JP, Hofstetter WL, van Hillegersberg R, Lin SH. Validation of a Nomogram Predicting Survival After Trimodality Therapy For Esophageal Cancer. Ann Thorac Surg 106(5):1541-1547, 2018. e-Pub 2018. PMID: 29932887.
229. Gawad NA, Kohner A, Ali T, Hofstetter W, Valentine A. Valproic Acid Attenuates Postoperative Psychosis Following Aggressive Resection of an Intracardiac Carcinoid Neuroendocrine Tumor: A Case Report. Psychosomatics 59(6):607-611, 2018. e-Pub 2018. PMID: 29703550.
230. (Hofstetter WL) ECSGPC. Predictors of Staging Accuracy, Pathologic Nodal Involvement and Overall Survival For cT2N0 Carcinoma Of The Esophagus. J Thorac Cardiovasc Surg. e-Pub 2018. PMID: 30558879.
231. Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SH. Prediction and Diagnosis of Interval Metastasis After Neoadjuvant Chemoradiotherapy For Oesophageal Cancer Using 18 F-FDG PET/CT. Eur J Nucl Med Mol Imaging 45(10):1742-1751, 2018. e-Pub 2018. PMID: 29663014.
232. Murray TA, Yuan Y, Thall PF, Elizondo JH, Hofstetter WL. A Utility-based Design For Randomized Comparative Trials With Ordinal Outcomes and Prognostic Subgroups. Biometrics 74(3):1095-1103, 2018. e-Pub 2018. PMID: 29359314.
233. Hofstetter WL. The Artificial Trachea: A Mission of Creativity, Perspiraction and Perseverance. J Thorac Cardiovasc Surg 156(3):1273-1274, 2018. e-Pub 2018. PMID: 29934005.
234. Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi B. Predictors of Survival Following Resection of Primary Sarcomas of the Chest Wall - A Large, Single-institution Series. J Surg Oncol 118(3):518-524, 2018. e-Pub 2018. PMID: 30109699.
235. Louie BE, Hofstetter W, Triadafilopoulos G, Weusten BL. Evaluation of a novel cryoballoon swipe ablation system in bench, porcine, and human esophagus models. Dis Esophagus 31(8), 2018. e-Pub 2018. PMID: 29481581.
236. Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Difference Between Men and Women. Ann Thorac Surg S0003-4975(18):1140-8, 2018. e-Pub 2018. PMID: 30118712.
237. Xi M, Hallemeier CL, Merrell KW, Liao Z, Murphy MAB, Ho L, Hofstetter WL, Mehran R, Lee JH, Bhutani MS, Weston B, Maru DM, Komaki R, Ajani JA, Lin SH. Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma. Ann Surg 268(2):289-295, 2018. e-Pub 2018. PMID: 28628563.
238. Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Lung Cancer. Ann Thorac Surg 106(1):272-279, 2018. e-Pub 2018. PMID: 29530770.
239. Moor MB, Ramakrishnan SK, Legrand F, Dolder S, Siegrist M, Durussel F, Centeno G, Firsov D, Hynes NE, Hofstetter W, Bonny O. Redox-Dependent Bone Alkaline Phosphatase Dysfunction Drives Part of the Complex Bone Phenotype in Mice Deficient for Memo1. JBMR Plus 2(4):195-205, 2018. e-Pub 2018. PMID: 30038965.
240. Hauser M, Siegrist M, Keller I, Hofstetter W. Healing of fractures in osteoporotic bones in mice treated with bisphosphonates - A transcriptome analysis. Bone 112:107-119, 2018. e-Pub 2018. PMID: 29680263.
241. Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SH. Severe Lymphopenia During Neoadjuvant Chemoradiation for Esophageal Cancer: A Propensity Matched Analysis of the Relative Risk of Proton Versus Photon-based Radiation Therapy. Radiother Oncol S0167-8140(17):32751-2, 2018. e-Pub 2018. PMID: 29248170.
242. Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes After Endoscopic Mucosal Resection Or Esophagectomy For Submucosal EsophagealAdenocarcinoma. J Thorac Cardiovasc Surg 156(1):406-413.e3, 2018. e-Pub 2018. PMID: 29605441.
243. Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Clinicoradiographic Predictors Of Aggressive Biology In Lung Cancer With Ground Gladd Components. Ann Thorac Surg 106(1):235-241, 2018. e-Pub 2018. PMID: 29534957.
244. Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BD. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved. Ann Surg Oncol 25(7):2012-2017, 2018. e-Pub 2018. PMID: 29748883.
245. Du KN, Feng L, Newhouse A, Mehta J, Lasala J, Mena GE, Hofstetter WL, Cata JP. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Anesth Analg 127(1):210-216, 2018. e-Pub 2018. PMID: 29757780.
246. Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic Variants in Cytokine Signaling Pathways and Clinical Outcomes in Early-Stage Lung Cancer Patients. J Thorac Cardiovasc Surg 155(6):2635-2645, 2018. e-Pub 2018. PMID: 29548588.
247. Goense L, van Rossum PSN, Xi M, Maru DM, Carter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SH. Preoperative Nomogram To Risk Stratify Patients For The Benefit Of Trimodality Therapy In Esophageal Adenocarcinoma. Ann Surg Oncol 25(6):1598-1607, 2018. e-Pub 2018. PMID: 29569125.
248. Hofstetter, WL. Open Modified En Bloc Ivor Lewis Esophgectomy: How I Teach It. Ann Thorac Surg 105(6):1583-1588, 2018. e-Pub 2018.
249. Giroux DJ, Van Schil P, Asamura H, Rami-Porta R, Chansky K, Crowley JJ, Rusch VW, Kernstine K, Hofstetter WL, Cancer Staging IAFTSOL, Committee PF. The IASLC Lung Cancer Staging Project: A Renewed Call to Participation. J Thorac Oncol 13(6):801-809, 2018. e-Pub 2018. PMID: 29476906.
250. Goense L, Merrell KW, Arnett AL, Hallemeier CL, Meijer GJ, Ruurda JP, Hofstetter WL, van Hillegersberg R, Lin SH. Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer. Ann Thorc Surg, 2018. e-Pub 2018.
251. Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD. The ypT Category Does Not Impact Overall Survival In Node Negative Gastric Cancer. J Surg Oncol 117(8):1721-1728, 2018. e-Pub 2018. PMID: 29949666.
252. Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MB. Natural History of Ground Glass Lesions among Patients with Previous Lung Cancer. Ann Thorac Surg 105(6):1671-1677, 2018. e-Pub 2018. PMID: 29432718.
253. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 53(5):960-966, 2018. e-Pub 2018. PMID: 29211849.
254. Hauser M, Siegrist M, Denzer A, Saulacic N, Grosjean J, Bohner M, Hofstetter W. Bisphosphonates reduce biomaterial turnover in healing of critical-size rat femoral defects. J Orthop Surg (Hong Kong) 26(3):2309499018802487, 2018. e-Pub 2018. PMID: 30270749.
255. Wang JF, Pu X, Zhang X, Chen K, Xi Y, Want J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang B. Variants With a Low Allele Frequency Detected in Genomic DNA Affect the Accuracy of Mutation Detection in Cell-free DNA by Next-generation Sequencing. Cancer 124(5):1061-1069, 2018. e-Pub 2018. PMID: 29178133.
256. Nelson DB, Dhupar R, Katkhuda R, Correa A, Coltsov A, Maru D, Sepesi B, Antonoff M, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes After Endoscopic Mucosal Resection Or Esophagectomy For Submucosal Esophageal Adenocarcinoma. J Thorac Cardiovasc Surg. e-Pub 2018. PMID: 29605441.
257. Ikoma N, Caormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajanie JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgewell BD. Racial Disparities in Preoperative Chemotherapy Use in Gastric Cancer Patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer 124(5):998-1007, 2018. e-Pub 2018. PMID: 29393964.
258. Schaverian MV, Hofstetter WL, Selber JC. Vascularized Jejunal Mesenteric Lymph Node Transfer for Lymphedema: A Novel Approach. Plast Reconstr Surg 141(3):468e-469e, 2018. e-Pub 2018. PMID: 29485606.
259. Betancourt Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EM. 18 FDG-PET/CT Is Useful In The Follow-Up Of Surgically Treated Patients With Oesophageal Adenocarcinoma. Br J Radiol 91(1082):20170341, 2018. e-Pub 2018. PMID: 29125331.
260. Goltsov AA, Fang B, Pandita TK, Maru DM, Swisher SG, Hofstetter WL. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells. Ann Thorc Surg 105(2):363-370, 2018. e-Pub 2018. PMID: 29223420.
261. Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani A. Early Metabolic Change After Induction Chemotherapy Predicts Histologic Response and Prognosis In Patients With Esophageal Cancer: Secondary Analysis Of A Randomized Trial. Target Oncol 13(1):99-106, 2018. e-Pub 2018. PMID: 29218623.
262. Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Li L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic Variants In Cytokine Signaling Pathways And Clinical Outcomes in Early-Stage Lung Cancer Patients Prognostic Value of PD-L1 mRNA Sequencing. J Thorac Cardiovasc Surg. e-Pub 2018. PMID: 29548588.
263. Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, Jr WW. Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer. Ann Thorac Surg 105(2):418-424, 2018. e-Pub 2018. PMID: 29217088.
264. Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Influence of Induction Chemotherapy in Trimodality Therapy-Eligible Oesophageal Cancer Patients: Secondary Analysis of a Randomized Trial. Br J Cancer 118(3):331-337, 2018. e-Pub 2018.
265. Harada K, Dong X, Estrella JS, Correa AM, Xu Y, Hofstetter WL, Sudo K, Onodera H, Suzuki K, Suzuki A, Johnson RL, Wang Z, Song S, Ajani JA. Tumor-Assocated Macrophage Infiltration Is Highly Associated with PD-L1 Expression In Gastric Adenocarcinoma. Gastric Cancer 21(1):31-40, 2018. e-Pub 2018. PMID: 28801853.
266. Palacioa D, Arom EM, Correa A, Betancourt-Cuellar SL, Hofstetter WL. Diagnosing Conduit Leak After Esophagectomy for Esophageal Cancer by Computed Tomography Leak Protocol and Standard Esophagram: Is Old School Still The Best?. Clin Imaging(51):23-29, 2018. e-Pub 2018. PMID: 29414520.
267. Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S. Galectin-3 Expression Is Prognostic In Diffuse Type Gastric Adenocarcinoma Confers Aggressive Phenotype And Can Be Targeted By YAP1/BET Inhibitors. Br J Cancer 118(1):52-61, 2018. e-Pub 2018. PMID: 29136404.
268. Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, Fournier KF, Mansfield P, Ajani JA, Badgwell BD. Evaluation of the American Joint Committee on Cancer 8th Edition Staging System for Gastric Cancer Patients after Preopterative Therapy. Gastric Cancer 21(1):74-83, 2018. e-Pub 2018. PMID: 28643144.
269. In H, Ravetch E, Langdon-Embry M, Palis B, Ajani J, Hofstetter WL, Kelsen DP, Sano T. The Newly Proposed Clinical and Post-Neoadjuvant Treatment Staging Classifications for Gastric Adenocarcinoma For The American Joint Committee on Cancer (AJCC) Staging. Gastric Cancer 21(1):1-9, 2018. e-Pub 2018. PMID: 28948368.
270. Elimova E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee JH, Weston BR, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Rogers JE, Skinner HD, Maru DM, Hofstetter WL, Ajani JA. Actionable Locoregional Relapses After Therapy Of Localized Esophageal Cancer: Insights From A Large Cohort. Oncology 94(6):345-353, 2018. e-Pub 2018. PMID: 29705797.
271. Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus After Bimodality Therapy in Patients With Esophageal Adenocarcinoma. Oncology 95(2):81-90, 2018. e-Pub 2018. PMID: 29843157.
272. Harada K, Wang, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial. Target Oncol. e-Pub 2017.
273. Betancourt Cuellar SL, Heller L, Palacio DP, Hofstetter WL, Marom EM. Intra and Extra-Thoracic Muscle Flaps and Chest Wall Reconstruction Following Resection of Thoracic Tumors. Semin Ultrasound CT MR 38(6):604-615, 2017. e-Pub 2017.
274. Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg 104(6):1821-1828, 2017. e-Pub 2017.
275. Betancourt Cuellar SL, Palacio DP, Benveniste MF, Carter BW, Hofstetter WL, Marom EM. Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations. Semin Ultrasound CT MR 38(6):571-583, 2017. e-Pub 2017.
276. Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan AA, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological Complete Response In Patients With Esophageal Cancer After The Trimodality Approach: The Association With Baseline Variables and Survival-The University of Texas MD Anderson Cancer Center Experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017. PMID: 28885712.
277. Xi M, Liao Z, Hofstetter WL, Komaki R, Ho L, Lin SH. F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit From Subsequent Esophagectomy After Chemoradiotherapy for Esopageal Adenocarcinoma. J Nucl Med 58(11):1756-1763, 2017. e-Pub 2017.
278. Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SH. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. Int J Radiat Oncol Biol Phys 99(3):667-676, 2017. e-Pub 2017. PMID: 29280461.
279. Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran RJ, Sepesi B. Long-Term Survival Outcomes Of Cancer-Directed Surgery For Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. Clin Oncol 35(29):3354-3362, 2017. e-Pub 2017. PMID: 28817374.
280. Carter BW, Erasmus JJ, Truong MT, Shepard JO, Hofstetter WL, Clarke R, Munden RF, Steele JR. Quality and Value of Subspecialty Reinterpretation of Thoracic CT Scans of PatientsReferred to a Tertiary Cancer Center. J Am Coll Radiol 14(8):1109-1118, 2017. e-Pub 2017.
281. Wadhwa R, Wang X, Baladangayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JA. Nuclear Expression of Gli-1 is Predictive of Pathologic Complete Response To Chemoradiation in Trimodality Treated Oesophageal Cancer Patients. Br J Cancer 117(5):648-655, 2017. e-Pub 2017.
282. Xi M, Xu C, Liao Z, Hofstetter WL, Blum Murphy M, Maru DM, Bhutani MS, Lee JH, Weston B, Komaki R, Lin SH. The Impact of Histology on Recurrence Patterns in Esophageal Cancer Treated with Definitive Chemoradiotherapy. Radiother Oncol 124(2):318-324, 2017. e-Pub 2017. PMID: 28687396.
283. Mizrak Kaya D, Dong X, Nogueras-Gonzalez GM, ZXu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Post-Trimodality Expression Levels of Metadherin (MDH) As A Prognostic Biomarker For Esophageal Adenocarcinoma Patients. Med Oncol 34(8):135, 2017. e-Pub 2017. PMID: 28685276.
284. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Ann Surg Oncol 24(8):2291-2301, 2017. e-Pub 2017. PMID: 27770339.
285. Xi M, Hallemeier CL, Merrell KW, Liao Z, Murphy MAB, Ho L, Hofstetter WL, Mehran R, Lee JH, Bhutani MS, Weston B, Maru DM, KomakiR, Ajani JA, Lin SH. Recurrence Risk Stratification After Preopterative Chemoradiation of Esophageal Adenocarcinoma. Ann Surg. e-Pub 2017.
286. Xi M, Liao Z, Deng W, Xu C, Komaki R, Blum M, Hofstetter WL, Ho L, Lin SH. A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer. J Thorac Oncol 12(6):1001-1010, 2017. e-Pub 2017. PMID: 28351804.
287. Mizrak KD, Wang X, Harada K, Blum-Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Jr MA, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. 101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy. Oncology 93(4):243-248, 2017. e-Pub 2017. PMID: 28683449.
288. Bassuner JK, Rice DC, Antonoff MB, Correa AM, WalshGL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?. Ann Thorac Surg 103(6):1710-1714, 2017. e-Pub 2017. PMID: 28366460.
289. Moreno AC, Verma V, Hofstetter WL Lin SH. Patterns of Care and Treatment Outcomes of Elderly Patients With Stage I Esophageal Cancer: Analysis of the National Cancer Data Base. J Thorac Oncol 12(7):1152-1160, 2017. e-Pub 2017. PMID: 28455149.
290. Xi M, Liao Z, Hofstetter WL, Komaki R, Ho L, Lin SH. FDG-PET Response After Induction Chemotherapy Can Predict Who Will Benefit From Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma. J Nucl Med 67(4):304-317, 2017. e-Pub 2017. PMID: 28556024.
291. Akkanti B, Rajagopal K, Patel KP, Aravind S, Nunez-Centanu E, Hussain R, Shabari FR, Hofstetter, WL, Vaporciyan AA, Banjac IS, Kar B, Gregoric ID, Loyalka P. Low-Flow Extracorporeal Carbon Dioxide Removal Using the Hemolung Respiratory Dialysis System to Facilitate Lung-Protective Mechanical Ventilation in Acute Respiratory Distress Syndrome. J Extra Corpor Technol 49(2):112-114, 2017. e-Pub 2017. PMID: 28638160.
292. van Rossum PS, Fried DV, Zhang L, Hofstetter WL van Vulpen M, Meijer GJ, Court LE, Lin SH. The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esohageal Cancer. J Nucl Med 57(5):691-700, 2017. e-Pub 2017. PMID: 26795288.
293. Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH. Cancer of the Esophagus and Esophagogastric Junction: Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J Clin, 2017. e-Pub 2017.
294. Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA. Utility of Endoscopic Ultrasound-guided Fine-needle Aspiration of Regional Lymph Nodes That Are Proximal To And Far From The Primary Distal Esophageal Carcinoma. Oncotarget 8(45):79356-79365, 2017. e-Pub 2017. PMID: 29108314.
295. Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani JA, Hofstetter WL, Lin S, Guha S, Kopetz S, Krishnan S, Maru D. Antitumor Effects of Cyclin Dependent Kinase 9 Inhibition in Esophageal Adenocarcinoma. Oncotarget 8(17):28696-28710, 2017. e-Pub 2017. PMID: 28404924.
296. Konda P, Ai D, Guerra CE, Rodriguez-Restrepo A, Mehran RJ, Rice D, Hofstetter W, Heir J, Kwater P, Gottumukkala V, Hernandez M, Cata JP. Identification of Risk Factors Associated With Postoperative Acute Kidney Injury After Esophagectomy for Esophageal Cancer. J Cardiothorac Vasc Anesth 31(2):474-481, 2017. e-Pub 2017. PMID: 27720491.
297. Shi A, Liao Z, Allen PK, Ho L, Murphy MB, Maru DM, Swisher SG, Hofstetter WL, Mehran RJ, Cox JD, Komaki R, Lin SH. Long-term Survival and Toxicity Outcomes of Intensity Modulated Radiation Therapy For The Treatment of Esophageal Cancer: A Large Single-Institutional Cohort Study. Adv Radiat Oncol 2(3):316-324, 2017. e-Pub 2017.
298. Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC. Salvage Pulmonary Resection After Sereotactic Body Radiotherapy: A Feasible and Safe Option for Local Failure in Selected Patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.
299. Betancourt C SL, Sabloff B, Carter BW, Benveniste MF, Correa AM, Maru DM, Ajani JA, Erasmus JJ, Hofstetter WL. Early Clinical Esophageal Adenocarcinoma (cT1): Utility of CT in Regional Nodal Metastasis Detection and Can the Clinical Accuracy Be Improved. Eur J Radiol 88:56-60, 2017. e-Pub 2017.
300. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol 12(2):375-382, 2017. e-Pub 2017. PMID: 27794500.
301. Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. J Thorac Oncol 12(2):368-374, 2017. e-Pub 2017. PMID: 27729298.
302. Murphy CC, Claire YY, Shahee NJ, Hofstetter WL, Sandler RS. An Age-Period Cohart Analysis of Obesity and Incident Esophageal Adenocarcinoma Amoung White Males. Dis Esophagus 30(3):1-8, 2017. e-Pub 2017.
303. Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg 265(1):122-129, 2017. e-Pub 2017. PMID: 26756758.
304. van Rossum PS, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, Carter BW, Court LE, Lin SH. The value of (18)F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. Eur J Nucl Med Mol Imaging 44(1):71-80, 2017. e-Pub 2017. PMID: 27511188.
305. Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg 21(1):62-67, 2017. e-Pub 2017. PMID: 27561633.
306. Murphy CC, Claire Yang Y, Shaheen NJ, Hofstetter WL, Sandler RS. An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Dis Esophagus. e-Pub 2016. PMID: 27862652.
307. Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Ann Thorac Surg 102(5):1653-1659, 2016. e-Pub 2016. PMID: 27526650.
308. Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Blackstone EH, Collaboration Investigators WEC. Recommendations for Pathologic Staging (pTNM) of Cancer of the Esophagus and Esophagogastric Junction For the 8th Edition AJCC/UICC Staging Manuals. Dis Esophagus 29(8):897-905, 2016. e-Pub 2016. PMID: 27905172.
309. Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Collaboration Investigators WEC. Recommendations for Clinical Staging (cTNM) of Cancer of the Esophagus and Esophagogastric Junction For the 8th Edition AJCC/UICC Staging Manuals. Dis Esophagus 29(8):913-919, 2016. e-Pub 2016. PMID: 27905171.
310. Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH, Collaboration Investigators WEC. Recommendations for Neoadjuvant Pathologic Staging (ypTNM) of Cancer of The Esophagus and Esophagogastric Junction for the 8th Edition AJCC/UICC Staging Manuals. Dis Esophagus 29(8):906-912, 2016. e-Pub 2016. PMID: 27905170.
311. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinbert LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mucahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H. Gastric Cancer, Version 3.2016 NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14(10):1286-1312, 2016. e-Pub 2016. PMID: 27697982.
312. Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH. Worldwide Esophageal Cancer Collaboration: Clinical Staging Data. Dis Esophagus 29(7):707-717, 2016. e-Pub 2016. PMID: 27731549.
313. Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. J Thorac Oncol S1556-0886(16):31141-8, 2016. e-Pub 2016.
314. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophagal Cancer: Interim Results From a Prospective Phase 1/11 Trial. J Thorac Oncol S1556-0864(16):31178-9, 2016. e-Pub 2016.
315. Wang Q, Zhou S, Court LE, Koay EJ, Zhang L, Zhang W, Lin SH, Tang C, Welsh JW, Hofstetter WL, Chang JY. Risk Stratifcation Incorporating Complementary Contrast Computed Tomography Texture Features for Prognosis in Primary Gastroesophageal Junction Adenocarcinoma. Int J Radiat Oncol Biol Phys 1;96(2S):S152-S153, 2016. e-Pub 2016. PMID: 27675655.
316. Rice TW, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus 29(7):715-723, 2016. e-Pub 2016. PMID: 27731548.
317. Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KL, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Cecconello I, Allum WH, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Lerut TE, Orringer MB, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus 29(7):724-733, 2016. e-Pub 2016. PMID: 27731547.
318. van Rossum PS, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, Carter BW, Court LE, Lin SH. The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. Eur J Nucl Med Mol Imaging. e-Pub 2016. PMID: 275111188.
319. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg 102(1):276-81, 2016. e-Pub 2016. PMID: 27083250.
320. Wang J, Suri JS, Allen PK, Liao Z, Komaki R, Ho L, Hofstetter WL, Lin SH. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer. Am J Clin Oncol 39(3):228-35, 2016. e-Pub 2016. PMID: 24710122.
321. van Rossum PS, Fried DV, Zhang L, Hofstetter WL, van Vulpen M, Meijer GJ, Court LE, Lin SH. The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer. J Nucl Med 57(5):691-700, 2016. e-Pub 2016. PMID: 26795288.
322. Shiozaki H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Jr MA, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgewell BD, Ajani JA. Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors. Oncology 91(1):55-60, 2016. e-Pub 2016. PMID: 27120436.
323. Spicer JD, Stiles BM, Sudarshan M, Correa AM, Ferri LE, Altorki NK, Hofstetter WL. Preoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial?. Ann Thorac Surg 101(4):1262-70, 2016. e-Pub 2016. PMID: 26916717.
324. Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Survival in Patients with Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg 101(3):1075-80; Discussion 1080-1, 2016. e-Pub 2016. PMID: 26680311.
325. Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, Swisher SG, Mehran RJ, Buchholz TA, Elting LS, Giordano SH. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer 122(6):917-28, 2016. e-Pub 2016. PMID: 26716915.
326. Hofstetter WL. Preoperative Chemoradiation in an Era of Suboptimal Clinical Staging. JAMA Surg 151(3):245-6, 2016. e-Pub 2016. PMID: 26558532.
327. Chen J, Yao ZX, Chen JS, Gi YJ, Muñoz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila M, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra L. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. J Clin Invest 126(2):527-42, 2016. e-Pub 2016. PMID: 26784546.
328. Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell B. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?. Ann Surg Oncol 23(2):626-32, 2016. e-Pub 2016. PMID: 26564243.
329. Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer. J Natl Compr Canc Netw 14(2):173-9, 2016. e-Pub 2016. PMID: 26850487.
330. Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer. Ann Thorac Surg 101(1):211-7, 2016. e-Pub 2016. PMID: 26279367.
331. Boys JA, Worrell SG, Chandrasoma P, Vallone JG, Maru DM, Zhang L, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Molena D, Watson TJ, DeMeester SR. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. J Gastrointest Surg 20(1):6-12; discussion 12, 2016. e-Pub 2016. PMID: 26408330.
332. Hofstetter WL. The enigmatic esophageal anastomosis. J Thorac Dis 7(9):E344-6, 2015. e-Pub 2015. PMID: 26543627.
333. Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D'Journo XB, Griffin SM, Hölscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJ. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 262(2):286-94, 2015. e-Pub 2015. PMID: 25607756.
334. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JA. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer. e-Pub 2015. PMID: 26321501.
335. Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, Betancourt SL, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection. Ann Thorac Surg. e-Pub 2015. PMID: 26233274.
336. Shewale JB, Correa AM, Baker CM, Villafane-Ferriol N, Hofstetter WL, Jordan VS, Kehlet H, Lewis KM, Mehran RJ, Summers BL, Schaub D, Wilks SA, Swisher SG, Collaborative Group UOTMAEC. Impact of a Fast-Track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges. Ann Surg 261(6):1114-23, 2015. e-Pub 2015. PMID: 25243545.
337. Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JA. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer. Clin Cancer Res 21(11):2580-90, 2015. e-Pub 2015. PMID: 25739674.
338. Guo C, Hao C, Shao R, Fang B, Correa AM, Hofstetter WL, Roth JA, Behrens C, Kalhor N, Wistuba II, Swisher SG, Pataer A. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget 6(13):11114-24, 2015. e-Pub 2015. PMID: 25798539.
339. Lin SH, Wang J, Allen PK, Correa AM, Maru DM, Swisher SG, Hofstetter WL, Liao Z, Ajani JA. A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer. J Gastrointest Oncol 6(1):45-52, 2015. e-Pub 2015. PMID: 25642337.
340. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 13(2):194-227, 2015. e-Pub 2015. PMID: 25691612.
341. Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang B. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett 357(1):179-85, 2015. e-Pub 2015. PMID: 25444907.
342. Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management. Ann Thorac Surg 99(2):414-20, 2015. e-Pub 2015. PMID: 25497068.
343. Hofstetter WL. Involved radial margins: mountain or molehill?. J Thorac Cardiovasc Surg 149(2):556-7, 2015. e-Pub 2015. PMID: 25455469.
344. Neishaboori N, Wadhwa R, Nogueras-González GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 2015. e-Pub 2015. PMID: 25765719.
345. He LR, Qiao W, Liao ZX, Komaki R, Ho L, Hofstetter WL, Lin SH. Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer 15:1095, 2015. e-Pub 2015. PMID: 25777421.
346. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma. Oncology 88(6):332-6, 2015. e-Pub 2015. PMID: 25765098.
347. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120(23):3635-41, 2014. e-Pub 2014. PMID: 25091571.
348. Dhupar R, Correa AM, Ajani J, Betancourt S, Mehran RJ, Swisher SG, Hofstetter WL. Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770-6, 2014. e-Pub 2014. PMID: 24152134.
349. Hofstetter W. Treatment of Clinical T2N0M0 Esophageal Cancer. Ann Surg Oncol 21(12):3713-4, 2014. e-Pub 2014. PMID: 25063008.
350. Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 2014. e-Pub 2014. PMID: 25225435.
351. Wu S, Wang L, Huang X, Cao M, Hu J, Li H, Zhang H, Sun X, Meng QH, Hofstetter WL, Roth JA, Swisher SG, Fang B. Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380. Bioorg Med Chem 22(19):5234-40, 2014. e-Pub 2014. PMID: 25182964.
352. Patel VR, Hofstetter WL, Correa AM, Agarwal A, Rashid A, Bhutani MS, Lin SH, Ajani JA, Swisher SG, Maru DM. Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation. Ann Thorac Surg 98(3):1064-71, 2014. e-Pub 2014. PMID: 25038008.
353. Gao W, Wang M, Wang L, Lu H, Wu S, Dai B, Ou Z, Zhang L, Heymach JV, Gold KA, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang B. Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non-Small Cell Lung Cancer Cells. J Natl Cancer Inst 106(9), 2014. e-Pub 2014. PMID: 25214559.
354. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-6, 2014. e-Pub 2014. PMID: 25157774.
355. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 2014. e-Pub 2014. PMID: 25099446.
356. Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RL. Hippo coactivator YAP1 upregulates SOX9 and endows stem-like properties to esophageal cancer cells. Cancer Res 74(15):4170-82, 2014. e-Pub 2014. PMID: 24906622.
357. Sudo K, Elimova E, Skinner HD, Hofstetter WL, Ajani JA. Critical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinoma. Reply to R. Gertler et al. J Clin Oncol 32(19):2112-3, 2014. e-Pub 2014. PMID: 24868018.
358. Juloori A, Tucker SL, Komaki R, Liao Z, Correa AM, Swisher SG, Hofstetter WL, Lin SH. Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy. J Thorac Oncol 9(4):534-40, 2014. e-Pub 2014. PMID: 24736077.
359. Gold KA, Kim ES, Liu DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WK. Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy. Clin Cancer Res 20(7):1946-54, 2014. e-Pub 2014. PMID: 24366692.
360. Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani JA, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SH. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Dis Esophagus 27(2):168-75, 2014. e-Pub 2014. PMID: 23621168.
361. Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol 8(1):142-9, 2014. e-Pub 2014. PMID: 24210755.
362. Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol 21(1):306-14, 2014. e-Pub 2014. PMID: 24197760.
363. Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Ajani JA. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology 86(5-6):336-9, 2014. e-Pub 2014. PMID: 24925190.
364. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 2013. e-Pub 2013. PMID: 24145339.
365. Lu H, Wang L, Gao W, Meng J, Dai B, Wu S, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang B. IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells. Mol Cancer Ther 12(12):2864-73, 2013. e-Pub 2013. PMID: 24130049.
366. Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MS, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SG. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24(11):2844-9, 2013. e-Pub 2013. PMID: 23975663.
367. Hofstetter WL. Evolving therapies in esophageal carcinoma. Thorac Surg Clin 23(4):ix-x, 2013. e-Pub 2013. PMID: 24199707.
368. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 2013. e-Pub 2013. PMID: 23994746.
369. Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up. Ann Thorac Surg 96(4):1138-45, 2013. e-Pub 2013. PMID: 23810174.
370. Godoy MC, Bruzzi JF, Viswanathan C, Truong MT, Guimarães MD, Hofstetter WL, Erasmus JJ, Marom EM. Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications. Abdom Imaging 38(5):974-93, 2013. e-Pub 2013. PMID: 23677485.
371. Murphy CC, Hofstetter WL, Correa AM, Ajani JA, Komaki RU, Swisher SG. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Dis Esophagus 26(7):708-15, 2013. e-Pub 2013. PMID: 23350713.
372. Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WL. Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. J Oncol Pract 9(5):233-9, 2013. e-Pub 2013. PMID: 23943906.
373. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, Cancer Group UOTMAE. The Influence of Histopathologic Tumor Vability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma. Ann Surg 258(3):500-7, 2013. e-Pub 2013. PMID: 24022442.
374. Ganeshan DM, Bhosale P, Munden RF, Hofstetter WL, Correa AM, Iyer R. Daphragmatic Hernia After Esophagectomy for Esophageal Malignancy. J Thorac Imaging 28(5):308-14, 2013. e-Pub 2013. PMID: 23222201.
375. Lee L, Ronellenfitsch U, Hofstetter WL, Darling G, Gaiser T, Lippert C, Gilbert S, Seely AJ, Mulder DS, Ferri LE. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg 217(2):191-9, 2013. e-Pub 2013. PMID: 23659947.
376. Crabtree TD, Kosinski AS, Puri V, Burfeind W, Bharat A, Patterson GA, Hofstetter W, Meyers BF. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg 96(2):382-90, 2013. e-Pub 2013. PMID: 23731608.
377. Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 86(5):885-91, 2013. e-Pub 2013. PMID: 23845841.
378. Murphy CC, Correa AM, Ajani JA, Komaki RU, Welsh JW, Swisher SG, Hofstetter WL. Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg 17(8):1359-69, 2013. e-Pub 2013. PMID: 23715646.
379. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg 95(6):1872-7; discussion 1877, 2013. e-Pub 2013. PMID: 23643547.
380. Skinner HD, McCurdy MR, Echeverria AE, Lin SH, Welsh JW, O'Reilly MS, Hofstetter WL, Ajani JA, Komaki R, Cox JD, Sandulache VC, Myers JN, Guerrero TM. Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncol 52(5):1002-9, 2013. e-Pub 2013. PMID: 22950385.
381. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol 24(5):1262-6, 2013. e-Pub 2013. PMID: 23247658.
382. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H, Cancer Network NC. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11(5):531-46, 2013. e-Pub 2013. PMID: 23667204.
383. Song S, Maru DM, Ajani JA, Chan CH, Honjo S, Lin HK, Correa A, Hofstetter WL, Davila M, Stroehlein J, Mishra L. Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. Cancer Res 73(7):159-169, 2013. e-Pub 2013. PMID: 23536563.
384. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Visceral pleural invasion is not predictive of survival in lung cancer patients with smaller tumor size. Society of Thoracic Surgeons 2013, 2013. e-Pub 2013.
385. Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology 85(4):204-7, 2013. e-Pub 2013. PMID: 24051869.
386. Guo C, Lu H, Gao W, Wang L, Lu K, Wu S, Pataer A, Huang M, El-Zein R, Lin T, Roth JA, Mehran R, Hofstetter W, Swisher SG, Wu X, Fang B. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLoS One 8(9):e74973, 2013. e-Pub 2013. PMID: 24069370.
387. Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation. Oncology 85(2):95-9, 2013. e-Pub 2013. PMID: 23860252.
388. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 2012. e-Pub 2012. PMID: 22853875.
389. Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys 84(5):1078-85, 2012. e-Pub 2012. PMID: 22867894.
390. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 94(6):1802-9, 2012. e-Pub 2012. PMID: 23063195.
391. Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-51, 2012. e-Pub 2012. PMID: 22939861.
392. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 2012. e-Pub 2012. PMID: 22831985.
393. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 2012. e-Pub 2012. PMID: 22921233.
394. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg 94(4):1104-11; discussion 1111-3, 2012. e-Pub 2012. PMID: 22939245.
395. Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MH. Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection. J Gastrointest Surg 16(9):1696-704, 2012. e-Pub 2012. PMID: 22644446.
396. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-622, 2012. e-Pub 2012. PMID: 22150920.
397. Swisher S, Ajani J, Correa A, Komaki R, Hofstetter W. Minimally invasice versis open oesophagectomy for oesophageal cancer. Lancet 380(9845):883, 2012. e-Pub 2012. PMID: 22959377.
398. Schier R, Hinkelbein J, Marcus H, Mehran R, El-Zein R, Hofstetter W, Swafford J, Riedel B. Preoperative Microvascular Dysfunction: A Prospective, Observational Study Expanding Risk Assessment Strategies in Major Thoracic Surgery. Ann Thorac Surg 94(1):226-233, 2012. e-Pub 2012. PMID: 22571880.
399. Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys 83(3):e345-51, 2012. e-Pub 2012. PMID: 22417808.
400. Hofstetter WL. Lymphadenectomy as a benchmark to surgical quality in esophagectomy: comment on "variation in lymph node examination after esophagectomy for cancer in the United States". Arch Surg 147(6):511-2, 2012. e-Pub 2012. PMID: 22786537.
401. Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh J. Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-9, 2012. e-Pub 2012. PMID: 22436793.
402. Welsh J, Settle SH, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z, Ajani JA. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118(10):2632-40, 2012. e-Pub 2012. PMID: 22565611.
403. Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba II. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol 7(5):833-40, 2012. e-Pub 2012. PMID: 22729036.
404. Thekkek N, Muldoon T, Polydorides AD, Maru DM, Harpaz N, Harris MT, Hofstetter W, Hiotis SP, Kim SA, Ky AJ, Anandasabapathy S, Richards-Kortum R. Vital-dye enhanced fluorescence imaging of GI mucosa: metaplasia, neoplasia, inflammation. Gastrointest Endosc 75(4):877-87, 2012. e-Pub 2012. PMID: 22301343.
405. Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A Phase II Study of a Paclitaxel Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. Int J Radiat Oncol Biol Phys 82(5):1967-72, 2012. e-Pub 2012. PMID: 21507583.
406. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2012. e-Pub 2012. PMID: 22172216.
407. Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc 75(2):242-53, 2012. e-Pub 2012. PMID: 22115605.
408. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal Cancer Dose Escalation using a Simultaneous Integrated Boost Technique. Int J Radiat Oncol Biol Phys 82(1):468-74, 2012. e-Pub 2012. PMID: 21123005.
409. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?. Ann Thorac Surg 93(1):207-12; discussion 212-3, 2012. e-Pub 2012. PMID: 21962263.
410. He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One 7(2):e31087, 2012. e-Pub 2012. PMID: 22348039.
411. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of Trimodallity-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation. Oncology 85(5):300-304, 2012. e-Pub 2012. PMID: 22964903.
412. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy. Oncology 82(2):108-113, 2012. e-Pub 2012. PMID: 22328056.
413. Hofstetter W. "Current and Future Options for Treating Esophageal Cancer: A Paradigm Shift Toward Organ-Sparing Therapies". Tex Heart Inst J 39(Ms. No. THIJ-12-2841):846-7, 2012. e-Pub 2012. PMID: 23304031.
414. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-Modulated Proton Therapy Further Reduces Normal Tissue Exposure During Definitive Therapy for Locally Advanced Distal Esophageal Tumors: A Dosimetric Study. Int J Radiat Oncol Biol Phys 81(5):1336-42, 2011. e-Pub 2011. PMID: 21470796.
415. Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 117(21):4823-33, 2011. e-Pub 2011. PMID: 21456015.
416. Kim JY, Hanasono MM, Fleming JB, Berry MD, Hofstetter WL. Combined Esophagectomy and Pancreaticoduodenectomy: Expanded Indication for Supercharged Jejunal Interposition. J Gastrointest Surg 15(10):1893-5, 2011. e-Pub 2011. PMID: 21541769.
417. Twaddell WS, Wu PC, Verhage RJ, Feith M, Ilson DH, Schuhmacher CP, Luketich JD, Brücher B, Vallböhmer D, Hofstetter WL, Krasna MJ, Kandioler D, Schneider PM, Wijnhoven BP, Sontag SJ. Barrett's esophagus: treatments of adenocarcinomas II. Ann N Y Acad Sci 1232:265-91, 2011. e-Pub 2011. PMID: 21950818.
418. Hofstetter WL. Invited commentary. Patterns of Lymph Node Metastasis and Survival for Upper Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 92(3):1097-8, 2011. e-Pub 2011. PMID: 21871305.
419. Mendelson J, Song S, Li Y, Maru DM, Mishra B, Davila M, Hofstetter WL, Mishra L. Dysfunctional transforming growth factor-ß signaling with constitutively active notch signaling in Barrett's esophageal Adenocarcinoma. Cancer 117(16):3691-702, 2011. e-Pub 2011. PMID: 21305538.
420. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, Cancer Network NC. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 9(8):830-87, 2011. e-Pub 2011. PMID: 21900218.
421. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-81, 2011. e-Pub 2011. PMID: 21623235.
422. Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol 35(7):1045-53, 2011. e-Pub 2011. PMID: 21602659.
423. Ajani JA, Blum MA, Welsh J, Hofstetter WL, Swisher SG. Celebrate or calibrate? We say calibrate. J Clin Oncol 29(19):2732; author reply 2732-3, 2011. e-Pub 2011. PMID: 21606421.
424. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: Modern Approaches to the Treatment of Localized Esophageal Cancer. Curr Oncol Rep 13(3):157-67, 2011. e-Pub 2011. PMID: 21365188.
425. Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 212(5):821-6, 2011. e-Pub 2011. PMID: 21435923.
426. Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus 24(3):147-52, 2011. e-Pub 2011. PMID: 21040152.
427. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial. J Clin Oncol 29(8):994-1000, 2011. e-Pub 2011. PMID: 21282546.
428. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(5):925-30, 2011. e-Pub 2011. PMID: 20960497.
429. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, Group M, of Medicine UORS, Group DF. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer 117(1):63-9, 2011. e-Pub 2011. PMID: 20803613.
430. He Y, Correa AM, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer A. The Role of PKR/eIF2a Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer. PLoS One 6(11):e24855, 2011. e-Pub 2011. PMID: 22102852.
431. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 2010. e-Pub 2010. PMID: 21136578.
432. Vallböhmer D, Hölscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schröder W, Bollschweiler E, Hofstetter W. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 252(5):744-9, 2010. e-Pub 2010. PMID: 21037429.
433. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Cancer Group MOTMAE, of Medicine TUORS, Group DF. A Clinical Nomogram Predicting Pathologic Lymph Node Involvement in Esophageal Cancer Patients. Ann Surg 252(4):611-617, 2010. e-Pub 2010. PMID: 20881767.
434. Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer 116(116(19)):4487-94, 2010. e-Pub 2010. PMID: 20629031.
435. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg 90(3):884-90; discussion 890-1, 2010. e-Pub 2010. PMID: 20732513.
436. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Chromosomal Aberrations Predict Malignant Progression of Esophageal Adenocarcinoma: a Genome-wide High-Density SNP Array Analysis. Cancer Prev Res (Phila) 3(9):1176-86, 2010. e-Pub 2010. PMID: 20651033.
437. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome with Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 2010. e-Pub 2010. PMID: 20732514.
438. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 2010. e-Pub 2010. PMID: 20609777.
439. Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison Between Established and the Worldwide Esophageal Cancer Collaboration Staging Systems. Ann Thorac Surg 89(6):1797-1803; discussion 1803-4, 2010. e-Pub 2010. PMID: 20494031.
440. Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LM. Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol 11(4):373-82, 2010. e-Pub 2010. PMID: 20171141.
441. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, Cancer Panel NG. Gastric cancer. J Natl Compr Canc Netw 8(4):378-409, 2010. e-Pub 2010. PMID: 20410333.
442. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 2010. e-Pub 2010. PMID: 20143431.
443. Zhou Y, Hofstetter WL, He Y, Hu W, Pataer A, Wang L, Wang J, Zhou Y, Yu L, Fang B, Swisher SG. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther 9(7):507-13, 2010. e-Pub 2010. PMID: 20215880.
444. Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH. Optimum lymphadenectomy for esophageal cancer. Ann Surg 251(1):46-50, 2010. e-Pub 2010. PMID: 20032718.
445. Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma. Oncology 78(5-6):316-322, 2010. e-Pub 2010. PMID: 20699623.
446. Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol 22(12):1612-21, 2009. e-Pub 2009. PMID: 19734842.
447. Kim MP, Hofstetter WL. Tumors of the diaphragm. Thorac Surg Clin 19(4):521-9, 2009. e-Pub 2009. PMID: 20112635.
448. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, Ajani JA. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer 115(22):5184-92, 2009. e-Pub 2009. PMID: 19685531.
449. Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-4458, 2009. e-Pub 2009. PMID: 19562780.
450. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 2009. e-Pub 2009. PMID: 19660349.
451. Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, Wang L, Xie K, Swisher SG, Fang B. Putative tumor-suppressive function of kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res 15(18):5688-95, 2009. e-Pub 2009. PMID: 19737957.
452. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-8; discussion 868-9, 2009. e-Pub 2009. PMID: 19699913.
453. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 2009. e-Pub 2009. PMID: 19699915.
454. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 2009. e-Pub 2009. PMID: 19619787.
455. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 75(7):598-603; discussion 603-4, 2009. e-Pub 2009. PMID: 19655604.
456. Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, Liao ZX. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 4(7):880-8, 2009. e-Pub 2009. PMID: 19458557.
457. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74(2):482-9, 2009. e-Pub 2009. PMID: 19289262.
458. Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD, Landreneau RJ, Clough ER, Watson TJ, Thoracic Surgeons SO. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg 87(6):1993-2002, 2009. e-Pub 2009. PMID: 19463651.
459. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 2009. e-Pub 2009. PMID: 19464452.
460. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 174(5):1940-8, 2009. e-Pub 2009. PMID: 19342367.
461. Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, Perrier ND. The fallen one: the inferior parathyroid gland that descends into the mediastinum. J Am Coll Surg 208(5):887-93; discussion 893-5, 2009. e-Pub 2009. PMID: 19476855.
462. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 2009. e-Pub 2009. PMID: 19156915.
463. Hu W, Hofstetter W, Wei X, Guo W, Zhou Y, Pataer A, Li H, Fang B, Swisher SG. Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound. J Pharmacol Exp Ther 328(3):866-72, 2009. e-Pub 2009. PMID: 19066342.
464. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal tumor length is independently associated with long-term survival. Cancer 115(3):508-16, 2009. e-Pub 2009. PMID: 19117343.
465. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-30, 2009. e-Pub 2009. PMID: 19130466.
466. Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 2009. PMID: 19021684.
467. Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Dis Esophagus 22(2):127-32, 2009. e-Pub 2009. PMID: 19021681.
468. Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979-84, 2008. e-Pub 2008. PMID: 18758299.
469. Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 2008. e-Pub 2008. PMID: 18670347.
470. Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, Lin A, Swisher SG, Fang B. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase. Cancer Gene Ther 15(9):616-24, 2008. e-Pub 2008. PMID: 18535619.
471. Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer 113(6):1302-8, 2008. e-Pub 2008. PMID: 18623381.
472. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 112(5):1020-7, 2008. e-Pub 2008. PMID: 18205187.
473. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 112(3):503-10, 2008. e-Pub 2008. PMID: 18072264.
474. Abraham SC, Krasinskas AM, Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TT. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 31(11):1719-25, 2007. e-Pub 2007. PMID: 18059229.
475. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-92; discussion 1692-3, 2007. e-Pub 2007. PMID: 17954086.
476. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-8, 2007. e-Pub 2007. PMID: 17975494.
477. Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol 31(11):1629-35, 2007. e-Pub 2007. PMID: 18059218.
478. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365-73; discussion 374-5, 2007. e-Pub 2007. PMID: 17643602.
479. Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JA. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev 16(6):1200-5, 2007. e-Pub 2007. PMID: 17548685.
480. Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 83(5):1805-13; discussion 1813, 2007. e-Pub 2007. PMID: 17462404.
481. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2007. e-Pub 2007. PMID: 17211865.
482. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109(1):125-34, 2007. e-Pub 2007. PMID: 17146785.
483. Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31(1):58-64, 2007. e-Pub 2007. PMID: 17197919.
484. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg 82(6):1982-7; discussion 1987-8, 2006. e-Pub 2006. PMID: 17126095.
485. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-974, 2006. e-Pub 2006. PMID: 16874819.
486. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12(15):4598-604, 2006. e-Pub 2006. PMID: 16899607.
487. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1(5):478-86, 2006. e-Pub 2006. PMID: 17409902.
488. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 2006. e-Pub 2006. PMID: 16456809.
489. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. e-Pub 2006. PMID: 16399296.
490. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 2005. e-Pub 2005. PMID: 16308005.
491. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80(6):1988-92; discussion 1992-3, 2005. e-Pub 2005. PMID: 16305830.
492. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391-8, 2005. e-Pub 2005. PMID: 16256794.
493. Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242(3):392-9; discussion 399-402, 2005. e-Pub 2005. PMID: 16135925.
494. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29(8):1079-85, 2005. e-Pub 2005. PMID: 16006804.
495. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 2005. e-Pub 2005. PMID: 15849517.
496. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-84; discussion 384-5, 2002. e-Pub 2002. PMID: 12192324.
497. Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 234(4):532-8; discussion 538-9, 2001. e-Pub 2001. PMID: 11573046.
498. Hofstetter W, Ortega A, Chiang M, Brown B, Paik P, Youn P, Beart RW. Abdominal insufflation does not cause hematogenous spread of colon cancer. J Laparoendosc Adv Surg Tech A 10(1):1-4, 2000. e-Pub 2000. PMID: 10706295.
499. Hofstetter WL, Vukasin P, Ortega AE, Anthone G, Beart RW. New technique for mesh repair of paracolostomy hernias. Dis Colon Rectum 41(8):1054-5, 1998. e-Pub 1998. PMID: 9715164.
500. Coburn WM, Russell MA, Hofstetter WL. Sucrose as an aid to manual reduction of incarcerated rectal prolapse. Ann Emerg Med 30(3):347-9, 1997. e-Pub 1997. PMID: 9287900.
501. Raboff W, Calobrace MB, Anthony G, Garner D, Greenwald D, Brant A, Hopkins B, Soonthon V, Noonan T, Hofstetter W. Mesh reinforcement increases bursting strength of intestinal anastomoses in steroid-treated rabbits. Am Surg 60(10):721-7, 1994. e-Pub 1994. PMID: 7944031.

Invited Articles

1. Hofstetter WL. Invited Commentary. Ann Thorac Surg 96(6):1867, 2012. e-Pub 2012. PMID: 22632488.
2. Hofstetter W. Invited commentary. Esophageal Leaks Repaired by Muscle Flaps. Ann Thorac Surg 88(3):973, 2009. e-Pub 2009. PMID: 19699930.
3. Leung KK, Maru D, Abraham S, Hofstetter WL, Mehran R, Anandasabapathy S. Optical EMR: confocal endomicroscopy-targeted EMR of focal high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 69(1):170-2, 2009. e-Pub 2009. PMID: 18582880.
4. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 2008. e-Pub 2008. PMID: 19059972.
5. Martin LW, Hofstetter W, Swisher SG, Roth JA. Management of intrathoracic leaks following esophagectomy. Adv Surg 40:173-190, 2006. e-Pub 2006. PMID: 17163101.

Review Articles

1. Hofstetter WL. Immunotherapy for Respectable Locally Advanced Esophageal Carcinoma. Ann Thorac Surg 118(1):130-140, 2024. e-Pub 2024. PMID: 38408631.
2. Hofstetter WL. Clinical Practice Guidelines for Esophagogastric Junction Cancer: Upper GI Oncology Summit 2023. Gastric Cancer 27(3):401-425, 2024. e-Pub 2024. PMID: 38386238.
3. Shah MA, Hofstetter WL, Kennedy EB, Expert Panel LAECG. Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update. J Clin Oncol 39(28):3182-3184, 2021. e-Pub 2021. PMID: 34406872.
4. Zhou N, Rajaram R, Hofstetter WL. Management of Locally Advanced Esophageal Cancer. Surg Oncol Clin N Am 29(4):631-646, 2020. e-Pub 2020. PMID: 32883463.
5. Shah MA, Kennedy EB, Catenacci DV, Deighton DC, Goodman KA, Malhotra NK, Willett C, Stiles B, Sharma P, Tang L, Wijnhoven BPL, Hofstetter WL. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol 38(23):2677-2694, 2020. e-Pub 2020. PMID: 32568633.
6. Zhou N, Hofstetter WL. Prognostic and Therapeutic Molecular Markers in the clinical Management of Esophageal Cancer. Expert Rev Mol Diagn 20(4):401-411, 2020. e-Pub 2020. PMID: 32067548.
7. Nelson DB, Tam AL, Mitchell KG, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Vaporciyan AA, Hofstetter WL. Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review. Ann Thorac Surg 107(6):1876-1883, 2019. e-Pub 2019. PMID: 30508527.
8. May RD, Frauchiger DA, Albers CE, Tekari A, Benneker LM, Klenke FM, Hofstetter W, Gantenbein B. Application of Cytokines of the Bone Morphogenetic Protein (BMP) Family in Spinal Fusion - Effects on the Bone, Intervertebral Disc and Mesenchymal Stromal Cells. Curr Stem Cell Res Ther 14(8):618-643, 2019. e-Pub 2019. PMID: 31455201.
9. Rajaram R, Hofstetter WL. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer. Thorac Surg Clin 28(4):473-480, 2018. e-Pub 2018. PMID: 30268293.
10. Little AG, Lerut AE, Harpole DH, Hofstetter WL, Mitchell JD, Altorki NK, Krasna MJ. The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction. Ann Thorac Surg 98(5):1880-5, 2014. e-Pub 2014. PMID: 25262396.
11. Hofstetter WL. Salvage esophagectomy. J Thorac Dis 6 Suppl 3:S341-9, 2014. e-Pub 2014. PMID: 24876940.
12. Hellmann MD, Chaft JE, William WN, Rusch V, Pisters KM, Kalhor N, Pataer A, Travis WD, Swisher SG, Kris MG, (Hofstetter W) UOTMALCCG. Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. Lancet Oncol 15(1):e42-50, 2014. e-Pub 2014. PMID: 24384493.
13. Davila ML, Hofstetter WL. Endoscopic management of Barrett's esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma. Thorac Surg Clin 23(4):479-89, 2013. e-Pub 2013. PMID: 24199698.
14. Varghese TK, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, Mitchell JD, Krasna MJ. The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg 96(1):346-56, 2013. e-Pub 2013. PMID: 23752201.
15. Marks JL, Hofstetter WL. Esophageal reconstruction with alternative conduits. Surg Clin North Am 92(5):1287-129, 2012. e-Pub 2012. PMID: 23026282.
16. Kim JY, Hofstetter WL. Esophagectomy after chemoradiation: who and when to operate. Semin Thorac Cardiovasc Surg 24(4):288-93, 2012. e-Pub 2012. PMID: 23465677.
17. Swisher SG, Hofstetter WL, Miller MJ. The supercharged microvascular jejunal interposition. Semin Thorac Cardiovasc Surg 19(1):56-65, 2007. e-Pub 2007. PMID: 17403459.

Other Articles

1. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC Correction to. Communications Medicine 4(1), 2024. PMID: 38942807.

Editorials

1. Hofstetter WL. Invited commentary. Ann Thorac Surg 93(5):1681, 2012. PMID: 22541197.
2. Bhutani MS, Hofstetter WL. Transesophageal EUS and EUS-FNA for lung cancer. Where do we go from here?. J Clin Gastroenterol 41(7):644-646, 2007. PMID: 17667046.

Abstracts

1. Bostock IC, Zhou N, Antonoff MB, Blum Murphy M, Lin S, Maru D, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher S, Vaporciyan A, Walsh GL, Hofstetter WL. Prolonged Neutrophilia Is Associated With Worse Outcomes After Esophagectomy. Proceedings from the STS 57th Virtual Annual Meeting, 2021. e-Pub 2021.
2. Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Maximum Standardized Uptake Value (SUVmax) on Preoperative PET. Proceedings from the STS 57th Virtual Annual Meeting, 2021. e-Pub 2021.
3. Zhou N, Feldman HA, Corsini EM, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WL. Definition of Salvage Esophagectomy Influences Survival for Trimodality and Bimodality Therapy for Esophageal Squamous Cell Carcinoma. Proceedings from the STS 57th Virtual Annual Meeting, 2021. e-Pub 2021.
4. Bostock IC, Hofstetter WL, Mehran RJ, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff MB. Travel Distance As A Barrier For Surveillance Imaging in Early staged Lung Cancer. Proceedings from the STS 57th Virtual Annual Meeting, 2021. e-Pub 2021.
5. Parikh K, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. After Hours Phone Calls from Postoperative Patients: Addressing Common Issues to Improve early Discharge Planning. Proceedings from the STS 57th Virtual Annual Meeting, 2021. e-Pub 2021.
6. Corsini EM, Wang Q, Tran HT, Mehran RJ, Antonoff MB, Rice DC, Walsh GL, Roth JA, Vaporciyan AA, Swisher SG, Hofstetter WL, a R, Bernatchez C, Wang J, Landry L, Roarty E, Zhanong J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi B. The Influence of Thoracic Surgical Approach on Peripheral Cytokines Over Time. Proceedings from the STS 56th Annual Meeting, 2020. e-Pub 2020.
7. Corsini E, Mitchell KG, Zhou N, Antonoff MB, Rice DC, Sepesi B, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Vaporciyan AA, Maru D, Lin SH, Ajani JA, Hofstetter WL. En-Bloc Esophagectomy Demonstrates Superior Locoregional Control With Equivalent Morbidity in Era of Neoadjuvant Therapy. Proceedings from the STS 56th Annual Meeting, 2020. e-Pub 2020.
8. Datar SS, Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher ST, Roth JA, Vaporciyan AA, Hofstetter WL, Loree J, Morris V, Antonoff MB. High Mutational Concordance Between Next Generation Sequencing Profiles of Colorectal Cancer and Pumonary Metastases. Proceedings of the STSA 66th Annual Meeting, 2019. e-Pub 2019.
9. Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin For Lung Cancer Resection Increases Risk of Reoperation For Bleeding. Proceedings of the AATS 99th Annual Meeting, 2019. e-Pub 2019.
10. Corsini EM, Mitchell KG, Mehran RJ, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB, Rice DC. Outcomes After Resection Of Thymic Neoplasms With Pleural Metastases. GTSC 2019, 2019. e-Pub 2019.
11. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Antonoff MB. Multidisciplinary Treatment of Thymic Neuroendocrine Tumors: Evaluation Of Surgery, Chemotherapy, and Radiation. Proceedings of the Multidisciplinary Thoracic Cancers Symposium, 2019. e-Pub 2019.
12. Corsini E, Mitchell K, Mehran R, Rice D, Sepesi B, Walsh G, Swisher S, Roth J, Hofstetter W, Vaporciyan A, Morris V, Antonoff M. Primary Colorectal Cancer Laterality Predicts Survival After Pulmonary Metastasectomy. Proceedings from the 55th Annual STS Meeting, 2019. e-Pub 2019.
13. Semenkovich T, Subramanian M, Hofstetter WL, Cassivi S, Stiles B, Chang A, Darling G, Broderick S, Fernandez F, Litle V, Puri V, Kozower B, Meyers B. Adjuvant Treatment for Node Positive Esophageal Cancer After Induction Therapy and Surgery Improves Survival - A Multisite Study. Proceedings of the 55 Annual STS Conference, 2019. e-Pub 2019.
14. Mitchell K, Cuentas EP, Nelson DB, Corsini E, Zhang J, Vaporciyan AA, Hofstetter WL, Mehran R, Swisher S, Rice DC, Sepesi B, Walsh G, Behrens M, Kalhor N, Weissferdt A, Moran C, Skoulidis F, Wisuba I, Fujimoto J, Roth J, Antonoff M. Intratumoral LKB1/STK11 Expression Correlates With Immune Cell Infiltration And Oncologic Outcomes Following Resection of Lung Adenocarcinoma. Proceedings of the 55th Annual STS Conference, 2019. e-Pub 2019.
15. Corsini E, Mitchell K, Mehran R, Rice DC, Sepesi B, Walsh G, Swisher S, Roth J, Hofstetter WL, Vaporciyan AA, Moris V, Antonoff M. Primary Colorectal Cancer Mutations Predict Surival and Recurrence After Pulmonary Metastasectomy. Proceedings of the 55th Annual STS Conference, 2019. e-Pub 2019.
16. Nelson DB, Niu J, Mitchell K, Sepesi B, Vaporciyan AA, Hofstetter WL, Walsh G, Swisher S, Roth J, Antonoff M, Mehran R, Rice DC. Persistent Opioid Use Among The Elderly After Lung Resection: A SEER-medicare Study. Proceedings of the 55th Annual STS Conference, 2019. e-Pub 2019.
17. Nelson DB, Mitchell K, Wang J, Fujimoto J, Behrens M, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran R, Rice DC, Walsh G, Swisher S, Moran C, Kalhor N, Weissferdt A, Wistuba I, Roth J, Antonoff M. Immune Regulary Markers of Lepidic-Pattern Adenocarcinomas Presenting as Ground Glass Opacities. Proceedings of the 55th Annual STS Conference, 2019. e-Pub 2019.
18. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Badgwell BD, Hofstetter WL. Predictors of Mediastinal Involovement After Neoadjuvant Chemoradiation In AdenocarcinomaOf The Gastroesophageal Junction. Proceedings of the STSA Annual 2018 Meeting, 2018. e-Pub 2018.
19. Nelson DB, Rice DC, Mitchell KG, Hofstetter WL, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Tsao AS, Gomez DR, Sepesi B, Mehran RJ. Poster: Return to Intended Oncologic Treatment (RIOT) After Extrapleural Pneumonectomy or Pleurectomy / Decortication for Malignant Pleural Mesothelioma. AATS International Thoracic Surgical Oncology Summit 2018, 2018. e-Pub 2018.
20. Mohammad Z, Nelson DB, Lapid D, Correa AM, Mitchell KG, Hofstetter WL, Mehran RJ, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Rice DC, Antonoff MB. Sex-Related Outcomes After Lobectomy For Stage l Non-Small Cell Lung Cancer: A Single Institution Experience. AATS International Oncology Summit, 2018. e-Pub 2018.
21. Nelson DB, Mitchell KG, Van Haren RM, Mena GE, Woodard T, Correa A, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MC, Roth JA, Heymach JV, Mehran RJ, Rice DC. Adjuvant Chemotherapy Is Facilitated by Enhanced Recovery After Thoracic Surgery: A Time-Series Analysis. Proceedings of the AATS International Oncology Summit, 2018. e-Pub 2018.
22. Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B. Defining The Role Of Adjuvant Radiotherapy For Malignant Pleural Mesothelioma: A Propensity Matched Landmark Analysis Of The National Cancer Database. Proceedings of the AATS International Oncology Summit, 2018. e-Pub 2018.
23. Mitchell KG, Nelson DB, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Antonoff MB. Tumor Cellular Proliferation Correlates With Immune Checkpoint Expression And Lymphocyte Infiltration In Resected Non-Small Cell LUng Cancer. Proceedings of the AATS International Oncology Summit, 2018. e-Pub 2018.
24. Mitchell KG, Nelson DB, Chang JY, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Antonoff MB. Surveillance Patterns After Treatment of Non-Small Cell Lung Cancer With Lobectomy And Stereotactic Body Radiotherapy. STSA 2018, 2018. e-Pub 2018.
25. Nelson DB, Nguyen QN, Tayob N, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Local Failure After Stereotactic Body Radiation Therapy (SBRT) Or Wedge Resection For Colorectal Pulmonary Metastases. Proceedings of the STS Annual 2018 Meeting, 2018. e-Pub 2018.
26. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Close Surgical Margins and Risks Of Local Treatment Failure After Wedge Resection Of Colorectal Pulmonary Metastases. Proceedings of the AATS Annual 2018 Meeting, 2018. e-Pub 2018.
27. Atay SM, Van Haren R, Niu J, Giordano S, Antonoff AM, Hofstetter WL, Mehran R, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Sepesi B. Pathologic Treatment Response is Associated with Increased Overall Survival in Patients Undergoing Neoadjuvant Chemotherapy Followed by Pneumonectomy. STS 2018, 2018. e-Pub 2018.
28. Van Haren R, Mehran R, Correa AM, Antonoff M, Baker CM, Hofstetter WL, Mena GE, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. J. Maxwell Chamberlain Memorial Paper for General Thoracic Surgery: Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer. Proceedings of the STS Annual 2018 Meeting, 2018. e-Pub 2018.
29. Nelson D, Godoy M, Benveniste M, Shewale J, Correa A, Spicer J, Hofstetter WL, Mehran R, Rice D, Sepesi B, Walsh G, Vaporciyan A, Swisher S, Roth J, Antonoff M. Clinicoradiographic Predictors of Aggressive Behavior in Resected Malignant Ground Glass Opacity Lesions. 43rd Annual Meeting of the Western Thoracic Surgical Association, 2017. e-Pub 2017.
30. Rice D, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy for Lung Cancer?. 2017 ISMICS Annual Scientific Meeting, 2017. e-Pub 2017.
31. Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. AATS 2017, 2017. e-Pub 2017.
32. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of Trimodality Therapy and Trends in Therapy for Malignant Pleural Mesothelioma. European Society of Thoracic Surgeons Annual Meeting 2017, 2017. e-Pub 2017.
33. Antonoff MB, Shewale J, Nelson DB, Rice D, Sepesi B, Hofstetter W, Mehran RJ, Vaporciyan AA, Walsh G, Swisher S, Roth J. Natural History of Ground Glass Lesions Among Patients with Previous Lung Cancer: Predictors of Progression. AATS Centennial 2017, 2017. e-Pub 2017.
34. Nelson DB, Correa A, Dhupar R, Goltsov A, Maru D, Sepesi B, Antonoff M, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Davila R, Betancourt S, Skinner H, Blum M, Hofstetter W. Endoscopic Mucosal Resection for Submucosal Esophageal Cancer. AATS 2017, 2017. e-Pub 2017.
35. Antonoff M, Ragalie W, Sepesi B, Roth J, Walsh G, Hofstetter W, Swisher S, Rice D, Vaporciyan A, Mehran R. Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection. 2017 Multidisciplinary Thoracic Cancers Symposium, 2017. e-Pub 2017.
36. Sepesi B, Parra Cuentes E, Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. Tumor Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. 2017 Multidisciplinary Thoracic Cancers Symposium, 2017. e-Pub 2017.
37. Sepesi B, Ye Y, Zhang L, Gu J, Ji L, Antonoff M, Hofstetter WL, Rice D, Mehran R, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic Variants in Cytokine Signaling Pathways Are Associated With Survival in Surgically Resectable Non-Small Cell Lung Cancer. AATS Centennial 2017, 2017. e-Pub 2017.
38. Goltsov A, Fang B, Pandita TK, Maru D, Swisher SG, Hofstetter WL. HER2 Amplification Confers Resistance to Targeted Therapy in Esophageal Adenocarcinoma Cells With Concomitant Amplification of MET. STS 2017, 2017. e-Pub 2017.
39. Bassuner J, Rice DC, Antonoff MB, Correa A, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran R. Polytetrafluoroethylene or collagen matrix for diaphragmatic reconstruction?. STS 53rd Annual Meeting, 2017. e-Pub 2017.
40. Rice D, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy? A Single Institution Comparison With 631 Contemporaneous VATS And Open Lobectomies. AATS 2017, 2017. e-Pub 2017.
41. Antonoff M, Correa A, Sepesi B, Rice D, Hofstetter W, Mehran R, Vaporciyan A, Walsh G, Swisher S, Roth J. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence with Use of Natural Language Processing. AATS 2017, 2017. e-Pub 2017.
42. Nelson DB, Rice DC, Niu J, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Giordano S, Mehran R, Sepesi B. Predictors of Therapy and Treatment Trends for Malignant Pleural Mesothelioma. ESTS 2017, 2017. e-Pub 2017.
43. Atay SM, Niu J, Giordano SH, Antonoff M, Heymach J, Hofstetter WL, Mehran R, Rice D, Roth JA, Vaporciyan A, Walsh G, William W, Swisher S, Sepesi B. Perioperative Outcomes and Downstaging Following Neoadjuvant Therapy For Lung Cancer - Analysis of the National Cancer Database. IASLC 2016, 2016. e-Pub 2016.
44. Atay S, Correa A, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Pulmonary Lobecomy on Clopidogrel. Southern Thoracic Society Association 63rd Annual Meeting, 2016. e-Pub 2016.
45. Sceusi E, Atay S, Correa A, Swisher S, Vaporciyan A, Roth J, Walsh G, Hofstetter W, Mehran R, Rice D, Sepesi B, Antonoff M. Outcomes for Patients with Surgically Resected Thymic Neuroendocrine Tumors. NANETS symposium: Exploring Novel Mechanisms and Therapies for Neuroendocrine Cancers, 2016. e-Pub 2016.
46. Shimodaira Y, Slack RS, Chen HC, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Harada K, Amlashi FG, Mizrak D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Komaki R, Walsh G, Ajani JA. Influence of Induction chemotherapy (IC) in Trimodality-Eligible Esophageal Cancer Patients: Secondary Analysis of a Randomized tria. ASCO 2016, 2016. e-Pub 2016.
47. Sepesi B, Parra Cuentas E, Rodriguez Canales J, Behrens C, Correa A, Antonoff M, Gibbons M, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba W. The Expression of Programmed Death 1 Ligand (PD-L1) in the Tumor and Tumor Infiltrating Macrophages Predicts Overall and Disease Free Survival in Surgically Resected Pathologic Stage I Non-Small Cell Lung Cancer. WTSA 2016, 2016. e-Pub 2016.
48. Antonoff MB, Correa A, Sepesi B, Nguyen QN, Walsh G, Swisher S, Vaporciyan A, Mehran R, Hofstetter WL, Rice D. Salvage pulmonary resection following SBRT: A feasible and safe option for local failure. AATS Annual Meeting 2016, 2016. e-Pub 2016.
49. Sceusi E, Miguel LJ, Mehran R, Kalhor N, Shaw K, Futreal A, Correa A, Moran C, Wistuba I, Junya F, Rao X, Swisher S, Vaporciyan A, Wang J, Antonoff M, Hofstetter WL, Rice D, Sepesi B, Walsh G, Roth J. Well Differentiated Neuroendocrine Carcinoma (Typical Carcinoid) with Mediastinal Lymph Node Metastases: Surgical Outcomes and Whole Exome Sequencing (WES). AATS Annual Meeting 2016, 2016. e-Pub 2016.
50. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Shiozaki H, Minsky B, Das P, Hofstetter W, Swisher S, Skinner H, Maru D, Matamoros A, Blum M, Lee J, Weston B, Bhutani M, Mansfield P, Badgwell B, Ajani J. Outcomes in older patients with localized gastric adenocarcinoma treated preoperatively. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
51. Elimova E, Kim SM, Wang X, Shimodaira Y, Sohn BH, Skinner HD, Lee JH, Weston BR, Bhutani MS, Minsky B, Rice DC, Hwang JE, Swisher SG, Hofstetter WL, Blum MA, Maru D, Ajani JA, Lee JS. Correlation of pretreatment p63-positive subtype of gastroesophageal adenocarcinoma (GEAC) with pathologic complete response (pathCR) in patients receiving preoperative chemoradiation. 2016 Gastrointestinal Cancers Symposium, 2016. e-Pub 2016.
52. Spicer JD, Shewale JB, Antonoff M, Correa AM, Hofstetter WL, Rice DC, Vaporciyan A, Mehran R, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Outcomes Following Chest Wall Resection. Southern Thoracic Surgical Association 2015, 2015. e-Pub 2015.
53. Sanchez N, Shewale JB, Baker C, Wilks SA, Correa AM, Sepesi B, Mehran R, Rice DC, Roth JA, Walsh GL, Swisher SG, Vaporciyan A, Hofstetter WL. Implications of Early Foley Removal in Thoracic Surgical Oncology Patients Utilizing Epidural Analgesia. Southern Thoracic Surgical Association 2015, 2015. e-Pub 2015.
54. Welsh JW, Seyedin SN, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Swisher SG, Blum MA, Nguyen Q, Minsky BD, Erasmus J, Lee JH, Bhutani MS, Komaki RU. Prospective Phase I/II Clinical Trial: Evaluating Dose Escalation for Esophageal Cancer. ASTRO 57th Annual meeting, 2015. e-Pub 2015.
55. Spicer JD, Shewale J, Correa AM, Heymach JV, Antonoff MB, Hofstetter WL, Mehran R, Roth J, Rice D, Sepesi B, Vaporciyan AA, William W, Walsh G, Swisher S. Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience. IASLC 2015, 2015. e-Pub 2015.
56. Spicer J, Shewale J, Sepesi B, Antonoff M, Correa A, Hofstetter WL, Rice D, Vaporciyan A, Mehran R, Walsh G, Roth J, Swisher S. The Role of Pneumonectomy After Neoadjuvant Chemotherapy for N2 Non-Small Cell Lung Cancer. Canadian Association of Thoracic Surgeons Annual Meeting 2015, 2015. e-Pub 2015.
57. Spicer J, Stiles B, Sudarshan M, Correa A, Ferri L, Altorki N, Hofstetter WL. Preoperative Chemoradiation Therapy vs Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Does Radiation Add Value?. Canadian Association of Thoracic Surgeons Annual Meeting 2015, 2015. e-Pub 2015.
58. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Indications For Counseling And Intervention After Pulmonary Resection: Results Of Post-discharge Nursing Telephone Assessments. Western Thoracic Surgical Association Annual Meeting 2015, 2015. e-Pub 2015.
59. Blum MA, Xiao L, Correa A, Wadhwa R, Skinner HD, Elimova E, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Analysis of Patients with Esophageal Cancer Following Trimodality Therapy: Pathological Complete Remission (PathCR) versus Non-PathCR. American Society of Clinical Oncology, 2015. e-Pub 2015.
60. Boys JA, Worrell SG, Chandrasoma P, Dunst CM, Hofstetter WL, Louie BE, Maru D, Vallone JG, Watson TJ, DeMeester SR. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. Digestive Disease Week 2010 148(4):S-1104, 2015. e-Pub 2015.
61. Spicer J, Stiles BM, Sudarshan M, Correa A, Ferri LE, Altorki NK, Hofstetter WL. Preoperative Chemoradiation Therapy vs Chemotherapy in Patients Undergoing En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Does Radiation Add Value?. STS 51st Annual Meeting, 2015. e-Pub 2015.
62. Antonoff MB, Hofstetter WL, Correa A, Bell J, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer: Is There a Role for Selective Surgery?. Society of Thoracic Surgeons, 2015. e-Pub 2015.
63. Elimova E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Planjery V, Nkis C, Skinner HD, Lee JH, Weston B, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Maru DM, Hofstetter WL, Ajani JA. Actionable Locoregional Failures (LRFs) after Therapy of Localized Esophageal Carcinoma (LEC): Surveillance Strategies and their Benefits. 2015 Gastrointestinal Cancers Symposium, 2015. e-Pub 2015.
64. Dhupar R, Correa A, Rice R, Bhutani M, Weston B, DaSilva A, Maru D, Betancourt S, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Less Accurate for Early Mid-Stage Patients: Implications for the Liberal Use of Endoscopic Resection. 51st Annual Meeting of The Society of Thoracic Surgeons:56, 2015. e-Pub 2015.
65. Sepesi B, Schmidt HM, Lada M, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Surgical Therapy Is an Important Multimodality Component in Patients With Distal Esophageal Adenocarcinoma Independent of Regional Lymph Node Location. 61st Annual Meeting, Southern Thoracic Surgical Association, 2014. e-Pub 2014.
66. Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki RU, Ho L, Hofstetter WL, Swisher SG, Elting LS, Giordano SH. Population-Based Analysis of Cause-Specific Mortality in Older Esophageal Cancer Patients Treated With Conformal Radiation Therapy or Intensity Modulated Radiation Therapy. 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, 2014. e-Pub 2014.
67. Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Walsh GL, Swisher SG, Hofstetter WL. Trends and Improving Outcomes of 882 Surgical Patients With Gastro-Esophageal Junction Adenocarcinoma – A Single Institution Experience. The International Society for Diseases of the Esophagus 2014, 2014. e-Pub 2014.
68. Gavini H, Sheu-Woc W, Singh A, Ross WA, Ajani JA, Bhutani MS, Weston BR, Hofstetter WL, Davila ML, Raju GS, Welsh JW, Lee JH. Is a Repeat Endoscopy (EGD) Necessary When Referred for Staging of Newly Diagnosed Esophageal Cancer?: A Comparison of Cancer Specialty Institution (CSI) With Other Institutions (Osf). Digestive Disease Week 2013, 2014. e-Pub 2014.
69. Hofstetter WL. Surgery Alone or Preoperative Therapy in cT2N0 Esophageal Cancer?. 94th Annual Meeting of American Association for Thoracic Surgery, 2014. e-Pub 2014.
70. Sepesi B, Hofstetter WL, Rice DC, Mehran RJ, Vaporciyan AA, Walsh G, Roth JA, Swisher SG. Experience with Primary and Metastatic Adenoid Cystic Carcinoma. 2014 Society of Surgical Oncology Annual Cancer Symposium, 2014. e-Pub 2014.
71. Francis AM, Correa AM, Betancourt-Cuellar SL, Kim JY, Sepesi B, Ajani JA, Komaki R, Erasmus J, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG. Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation. Academic Surgical Congress 2014, 2014. e-Pub 2014.
72. Shiozaki H, Sudo K, Wadhwa R, Elimova E, Slack R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Hofstetter WL, Ajani JA. Effect of the distribution of lymph node metastases on outcomes for trimodality-eligible patients with esophageal and esophagogastric junction adenocarcinoma (EAC). 2014 ASCO Annual Meeting, 2014. e-Pub 2014.
73. Betancourt-Cuellar SL, Hofstetter WL, Correa AM, Mawlawi OR, Palacio DM, Marom EM. Prognostic Value of Metabolic Tumor Volume in Patients with Esophageal Carcinoma. Radiological Society of North America, 2013. e-Pub 2013.
74. Palacio DM, Hofstetter WL, Correa AM, Betancourt-Cuellar SL, Marom EM. Diagnosing Leak after Esophagectomy for Esophageal Cancer by CT-esophageal Protocol (CTEP) and Standard Esophagram (SE): Is the Old School Still the Best School?. Radiological Society of North America, 2013. e-Pub 2013.
75. Kim MP, Correa AM, Blackmon SH, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Preoperative Flourodeoxyglucose-Positron Emission Tomography Scan with Positive N1 Disease Does Not Predict Worse Survival in Pathologic Stage II Patients. IASLC 2013, 2013. e-Pub 2013.
76. Wang J, Lin SH, Allen PK, Juloori A, Lee JK, Komaki R, Liao Z, Swisher SG, Hofstetter WL, Ajani JA. Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival Outcomes in Esophageal Cancer Patients Treated With Definitive Chemoradiation. ASTRO 55th Annual Meeting, 2013. e-Pub 2013.
77. Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Skinner HD, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Customizing surveillance of patients with esophageal or esophagogastric junction adenocarcinoma (E-EGA) after trimodality therapy (TMT). American Society of Clinical Oncology, 2013. e-Pub 2013.
78. Singh A, Hofstetter WL, Bhattacharya A, Ladha HS, Qiao W, Ross WA, Bhutani MS, Krishna SG, Ajani JA, Maru D, Lee JH. Accuracy of Endoscopic Ultrasound in Differentiation of Mucosal and Submucosal Esophageal Cancer At a Tertiary Cancer Care Center. Digestive Disease Week 2013, 2013. e-Pub 2013.
79. Singh A, Bhattacharya A, Ladha HS, Kwak NH, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Erasmus JJ, Hofstetter WL, Swisher SG, Lee JH. Comparison of Lymph Node Detection on PET and EUS in Patients With Esophageal Cancer. Digestive Disease Week 2013, 2013. e-Pub 2013.
80. Skinner HD, Xu E, Lee JH, Bhutani MS, Weston B, Suzuki A, Hofstetter WL, Komaki R, Ajani JA, Wu X. A validated miRNA expression profile for response to neoadjuvant therapy in esophageal cancer. 2013 ASCO Annual Meeting, 2013. e-Pub 2013.
81. Stephens A, Rice D, Swisher S, Vaporcyian A, Hofstetter W, Walsh G, Mehran R, Roth J. VATS lobectomy is Associated with Improved Short-Term and Long-Term Outcomes Compared to Open Lobectomy for C-Stage I NSCLC: A Propensity-Matched Analysis of 963 Cases. 21st European Conference of General Thoracic Surgery ESTS:143, 2013. e-Pub 2013.
82. Francis AM, Sepesi B, Correa A, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh J, Swisher SG, Hofstetter WL. Long Term Survival and Recurrence Rates Following Trimodality Therapy of Esophageal Adenocarcinoma – The Influence of Histologic Tumor Viability. ASA 2013 Annual Meeting, 2013. e-Pub 2013.
83. Taketa T, Xiao L, Suzuki A, Blum MA, Sudo K, Lee JH, Weston B, Bhutani MS, Lin SH, Wadhwa R, Swisher S, Hofstetter WL, Ajani JA. 16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation. 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
84. Crabtree TD, Puri V, Burfeind W, Kosinski A, Bharat A, Patterson GA, Hofstetter W, Meyers BF. Evaluation of the Reliability of Clinical Staging of T2N0 Esophageal Cancer: A Review of the STS Database. STS 49th Annual Meeting, 2013. e-Pub 2013.
85. Swisher S, Moughan J, Komaki R, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett C. Final Results of RTOG 0246: A Phase II Study of Selective Surgical Resection for Locoreginally Advanced Esophageal Cancer Treated with a Paclitaxel Based Chemoradiation Regimen. ASCO 2013 GI Cancer Symposium, 2013. e-Pub 2013.
86. David EA, Wai C, Correa AM, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Thall PF, Mehran RJ. Visceral Pleural Invasion is not predictive of survival In NSCLC patients with small tumors in a North American patient population. The Society of Thoracic Surgery 49th Annual Meeting, 2013. e-Pub 2013.
87. Kim JY, Nelson R, Chen SL, Hofstetter W, Kim J, Swisher SG, Raz DJ. Does the Seventh Edition AJCC Staging System for Esophageal Adenocarcinoma Predict Survival after Neoadjuvant Therapy?. STS 49th Annual Meeting, 2013. e-Pub 2013.
88. Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele NB, Erasmus JJ, Heymach J, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Gold K, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, William W, Wistuba I, Swisher SG. The Impact of Histopathologic Tumor Viability on AJCC 7th Lung Cancer Staging Following Neoadjuvant Chemotherapy. STS 2013, 2013. e-Pub 2013.
89. Suzuki A, Xiao L, Taketa T, Sudo K, Blum MA, Komaki R, Liao ZX, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S, Ajani JA. Various clinical outcomes in patients with esophageal or gastroesophageal junction (E-GEJ) adenocarcinoma undergoing trimodality therapy: Prognostic implications. 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
90. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy. 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
91. Wadhwa R, Taketa T, Correa AM, Sudo K, Blum MA, Campagna MC, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases following trimodality therapy (TMT) in patients with esophageal and gastroesophageal (E-EGCJ) cancer. 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
92. Campagna MC, Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of relapse in patients with esophageal and esophagogastric junction (E-EGJ) cancer with surgical stage after trimodality therapy (TMT): Implications for customized surveillance. 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
93. Sudo K, Xiao L, Wadhwa R, Taketa T, Blum MA, Skinner HD, Lee JH, Bhutani MS, Weston B, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Pattern of local-regional relapse and survival after bimodality therapy for esophageal cancer: Implications for the surveillance strategy. ASCO 2013, 2013. e-Pub 2013.
94. Wadhwa R, Xiao L, Sudo K, Taketa T, Blum MA, Skinner HD, Lee JH, Bhutani MS, Weston B, Komaki R, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Frequency of relapse over time based on baseline stage in esophageal cancer patients treated with definitive chemoradiation (DCRT). ASCO GI 2013, 2013. e-Pub 2013.
95. Hofstetter W, Clemens MW, Garvey PB, Corkum JP, Liu J, David E, Baumann DP, Butler CE. Function Outcomes in Reconstruction of Massive Chest Wall Defects: A 17-Year Experience. 17th World Congress International Confederation for Plastic, Reconstructive and Aesthetic Surgery, Santiago, Chile, 2013. e-Pub 2013.
96. Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic Hernia After Esophagectomy in 440 Patients with Long-term Follow-up. 59th Southern Thoracic Surgical Association, 2012. e-Pub 2012.
97. Skinner HD, McCurdy M, Echeverria A, Lin S, Welsh J, O'Reilly M, Hofstetter W, Ajani J, Komaki R, Guerrero T. Metformin Use is Associated With Improved Response to Neoadjuvant Chemoradiation in Esophageal Adenocarcinoma. ASTRO 54th Annual Meeting, 2012. e-Pub 2012.
98. Suzuki A, Xiao L, Taketa T, Blum MA, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Rice DC, Mehran RJ, Maru DM, Erasmus JJ, Hofstetter WL, Swisher S, Ajani JA. Customization of treatment for patients with esophageal adenocarcinoma (EAC) who achieve clinical complete response (cCR) after chemoradiation using initial standardized uptake value (iSUV) of 18f-fluorodeoxyglucose PET. American Society of Clinical Oncolgoy 2012 Annual Meeting, 2012. e-Pub 2012.
99. Cheedella NKS, Suzuki A, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Maru DM, Vaporciyan AA, Taketa T, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Walsh GL, Swisher S, Ajani JA. Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT). 2012 ASCO Annual Meeting, 2012. e-Pub 2012.
100. Taketa T, Correa AM, Suzuki A, Blum MA, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Outcome of 58 trimodality-eligible esophagogastric cancer (EC) patients who achieved clinical complete response (cCR) after preoperative chemoradiation but then declined surgery. American Society of Clinical Oncology, 2012. e-Pub 2012.
101. Sepesi B, Swisher SG, Walsh GL, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Hofstetter WL. Omental Reinforcement of the Thoracic Esophagogastric Anastomosis - An Analysis of Leak and Reintervention Rates in Planned and Salvage Esophagectomy Patients. American Association of Thoracic Surgery, 2012. e-Pub 2012.
102. Blum MA, Hayashi Y, Xiao L, Suzuki A, Sabloff B, Maru DM, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer (EC). ASCO 2012 Meeting, 2012. e-Pub 2012.
103. Agarwal A, Appleberry T, Guha S, Ajani J, Hofstetter W, Swisher S, Lennon P, Rashid A, Maru D. Novel Chromosomal Abnormalites in Barrett's Esophagus and Esophageal Adenocarcinoma Identified by Array Comparative Genomic Hybridization (CGH). United States and Canada Academy of Pathology Meeting 2012, 2012. e-Pub 2012.
104. Blackmon SH, Stephens E, Correa AM, Hofstetter WL, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrence in the Lung and Survival in Pulmonary Metastasectomy for Colorectal Carcinoma Patients. 48th Annual Society of Thoracic Surgeons Meeting, 2012. e-Pub 2012.
105. Suzuki A, Xiao L, Hayashi H, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Maru D, Rice DC, Hofstetter WL, Erasmus JJ, Swisher S, Ajani JA. Nomograms for prognostication of patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. ASCO 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
106. Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
107. Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, Swisher S, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH. Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer. 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
108. Marks JL, Hofstetter WL, Correa AM, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma. Society of Thoracic Surgeons 48th Annual Meeting, 2012. e-Pub 2012.
109. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Yu P, Hofstetter WL. Super-Charged Pedicled Jejunal Interposition for Esophageal Replacement: A 10-Year Experience. 48th Annual Society of Thoracic Surgeons, 2012. e-Pub 2012.
110. Marom EM, Moran CA, Piu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed Tomography Findings Predicting Invasiveness of Thymoma. 40th Congress of the International Society of Oncology and Biomarkers, October 13-17, 2012; Jerusalem, Israel, 2012. e-Pub 2012.
111. Myles BA, Lin SH, Tucker SL, Ajani JA, Hofstetter WL, Swisher SG, Ho L, Komaki R, Cox JD, Liao Z. Long Term Outcomes Comparing Three-dimensional Conformal Radiation Therapy to Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancer: The MD Anderson Experience. ASTRO 53rd Annual Meeting, 2011. e-Pub 2011.
112. He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba I, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant Signal Transduction and DNA Damage Response pathways in Primary Lung Cancer. ISLAC 2011 6(6, Supp 2):S972, 2011. e-Pub 2011.
113. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutani MS, Lin SH, Welsh J, Maru D, Swisher S, Ajani JA. The association between body mass index and baseline clinical stage of esophageal carcinoma. 2011 ASCO Annual Meeting, 2011. e-Pub 2011.
114. Gold KA, Lee JJ, Ping Y, Behrens C, Liu D, H-Y L, Koo JS, Lotan R, Soto LM, Rinsurongkawong, Stewart DJ, Lippman SM, Wistuba II, Hong WK, Kim ES, Swisher SG, Hofstetter WL. Biologic Risk Model for Recurrence in Resected Early Stage Non-Small Cell Lung Cancer (ES NSCLC). Present at The American Society of Clinical Oncology's 47th Annual Meeting, Chicago, Illinois, June 3-7, 2011, 2011. e-Pub 2011.
115. Harvin JA, Lahat G, Correa AM, Lee JJ, Maru D, Ajani J, Marom E, Welsh J, Bhutani MS, Walsh GL, Roth JA, Mehran RJ, Vaporciyan AA, Rice DC, Swisher SG, Hofstetter W. Neoadjuvant Chemoradiation followed by Surgery for Esophageal Adenocarcinoma: Significance of Microscopically Positive Circumferential Margins. 91st Annual Meeting American Association for Thoracic Surgery:89, 2011. e-Pub 2011.
116. Gold KA, William WN, Lee JJ, Vaporciyan AA, Herbst RS, Tse W, Stewart D, Hofstetter WL, Wistuba II, Swisher SG, Lippman SM, Kim ES. Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with resectable non-small cell lung cancer (NSCLC). Targeted Therapies for Lung Cancer Annual Meeting, 2011. e-Pub 2011.
117. Estrella JS, Hofstetter W, Correa AM, Ajani J, Swisher S, Rashid A, Maru D. Measurement of Depth of Invasion, Submucosal and Lymphovascular Invasion (LVI) Predicts Lymph Node (LN) Involvement in T1 Esophageal Adenocarcinoma (EAC). Invasion of Duplicated Muscularis Mucosae (MM) Has Similar Risk of LN Involvement as Mucosal Invasion. United States and Canadian Academy of Pathology 2011, 2011. e-Pub 2011.
118. Goodarzi M, Kanhere R, Corley L, Correa A, Ajani J, Swisher S, Hofstetter W, Rashid A, Maru D. Sox-9 Immunohistochemistry Demonstrates Abnormal Distribution of Gastrointestinal Stem Cells in Specialized and Non-Specialized Barrett's Mucosa. United States and Canadian Academy of Pathology 2011, 2011. e-Pub 2011.
119. Kim JY, Correa AM, Swisher SG, Rice DC, Walsh GL, Vaporciyan AA, Mehran RJ, Roth JA, Bhutani M, Maru D, Welsh J, Ajani J, Rohren E, Hofstetter WL. Does the Timing of Esophagectomy After Neoadjuvant Chemoradiation Affect Outcome?. The Society of Thoracic Surgeons, 47th Annual Meeting, 2011. e-Pub 2011.
120. Suzuki A, Xiao L, Hayashi Y, Welsh J, Lin SH, Lee JH, Bhutani MS, Hofstetter WL, Mehran RJ, Ajani JA. Value of the primary tumor initial standardized uptake value (iSUV) of 18F-fluorodeoxyglucose positron emission tomography (PET) to predict overall survival (OS) in patients with esophageal or gastroesophageal junction carcinoma undergoing definitive chemoradiotherapy. 2011 Gastrointestinal Cancers Symposium, 2011. e-Pub 2011.
121. Lin SH, Komaki R, Liao Z, Wei C, Cai H, Chang JY, Hofstetter WL, Swisher SG, Ajani J, Cox JD. Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer. 2011 Poster Presentation, American Radium Society 2011 Annual Meeting, Palm Beach, Florida, April 30-May 4, 2011, 2011. e-Pub 2011.
122. Ajani JA, Wang X, Hayashi Y, Maru DM, Welsh J, Hofstetter WL, Lee JH, Bhutani MS, Suzuki A, Berry D, Izzo J. Validated Biomarker Signatures That Predict Pathologic Response To Preoperative Chemoradiation Therapy (CTRT) With High Specificity and Desirable Sensitivity Levels In Patients With Esophageal Cancer (EC). American Society of Clinical Oncology, 2011. e-Pub 2011.
123. Suzuki A, Xiao L, Hayashi Y, Welsh J, Lin SH, Hofstetter W, Mehran RJ, Lee JH, Bhutani MS, Liao Z, Ajani JA. Prognostic significance of post-treatment standardized uptake value (pSUV) of positron emission tomography (PET) to predict overall survival (OS) and relapse free survival (RFS) in patients with esophageal or gastroesophageal cancer treated with definitive chemoradiotherapy. Presented at The American Society of Clinical Oncology's 47th Annual Meeting, June 3-7, 2011, Chicago, Illinois, 2011. e-Pub 2011.
124. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The influence of pretreatment body mass index on long-term prognosis of patients with esophageal carcinoma after surgery. Gastrointest Cancer Res(Supplement 2):S7, 2010. e-Pub 2010.
125. Welsh JW, Riley B, Palmer MB, Amin MV, Komaki R, Gomez, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity Modulated Proton Therapy Allows Dose Escalation and Normal-Tissue Sparing in Locally Advanced Distal Esophageal Tumors. ASTRO 52nd Annual Meeting, 2010. e-Pub 2010.
126. Blackmon SH, Stephens EH, Correa AM, Roth JA, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression following chemotherapy is a novel predictor of poor outcome following pulmonary metastasectomy in sarcoma patients. J Am Coll Surg Supp, 2010. e-Pub 2010.
127. Bektas M, Oruc N, Qiao W, Lee JH, Ross WA, Ajani JA, Hofstetter WL, Swisher S, Bhutani MS. Which Technique Predicts Histopathologic Regression After Neoadjuvant Therapy for Esophageal Cancer?. Digestive Disease Week 2010, 2010. e-Pub 2010.
128. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Ajani JA, Erasmus J, Komaki R, Lee JHL, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Peters JH, Watson TJ, Swisher SG. A Clinical Nomogram Predicting Pathologic Lymph Node Involvement in Esophageal Cancer Patients. American Surgical Association 130th Annual Meeting:77, 2010. e-Pub 2010.
129. Kim MP, Correa A, Moran C, Erasmus J, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA. Resection of lung cancer in lymphoma survivors. STS 46th Annual Meeting:204, 2010. e-Pub 2010.
130. Kim MP, Hofstetter WL, Correa A, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Swisher SG. Pathologic T0N1 after neoadjuvant therapy and surgery for esophageal cancer: an orphan status. STS 46th Annual Meeting:174-175, 2010. e-Pub 2010.
131. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The Influence of Pretreatment Body Mass Index on Long-Term Prognosis of Patients with Esophageal Carcinoma After Surgery. 2010 ASCO Meeting, 2010. e-Pub 2010.
132. Swisher SG, Hofstetter WL Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru DM, Mehran RJ, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome With Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. Southern Thoracic Surgical Association 2009, 2009. e-Pub 2009.
133. Gaur P, Hofstetter WL, Bekele NB, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Staging of Gastroesophageal Adenocarcinomas: A Comparison Between Esophageal Staging, Gastric Staging, and a Novel Worldwide Esophageal Cancer Collaboration Staging System. STSA 56th Annual Meeting 2009, 2009. e-Pub 2009.
134. Correa AM, Hayashi Y, Hofstetter WL, Komaki R, Vaporciyan AA, Rice DC, Walsh GL, Lee JH, Bhutani MS, Ross WA, Liao Z, Swisher SG, Ajani JA. In Patients with Clinical T2N0M0 Esophageal Cancer, Surgery First or Preoperative Chemoradiotherapy?. 2009 Gastrointestinal Oncology Conference, 2009. e-Pub 2009.
135. Hofstetter WL, Hightower CE, Morris GS, Sun XG, Riedel BJ, Mehran RJ, Hearon CM. Changes in cardiopulmonary reserves associated with neoadjuvant therapy in patients with esophageal cancer. 2009 ASCO Annual Meeting 27(15S), 2009. e-Pub 2009.
136. Muldoon TJ, Anandasabapathy S, Hofstetter WL, Maru D, Richards-Kortum R. High-resolution microendoscopy and image analysis for early cancer detection in gastrointestinal epithelium. Digestive Disease Week 2009, 2009. e-Pub 2009.
137. Maru DM, Correa AM, Tong Z, Wang H, Wu TT, Corley L, Krishnan S, Ajani JA, Swisher SG, Rashid A, Hofstetter WL, Guha S. Loss of Neutrophil Gelatinase Associated Lipocalin (NGAL) Expression in Esophageal Adenocarcinoma (EAC) Is Associated with Higher Pathologic Stage and Poor Survival. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
138. Rice DC, Lee JH, Eapen JG, Stewart J, Hofstetter WL, Mehran R, Vaporciyan AA, Walsh GL, Swisher SG. Mediastinal Staging for Mesothelioma: Endoscopic Ultrasound or Mediastinoscopy?. 45th Annual Meeting Society of Thoracic Surgeons:18, 2009. e-Pub 2009.
139. Hofstetter WL, Maru DM, Correa A, Shah N, Lee JH, Ajani JA, Erasmus JJ, Komaki R, Anandasabapathy S, Swisher SG. Salvage resection for esophageal adenocarcinoma after failed definitive chemoradiation. 2009 Gastrointestinal Cancers Symposium, 2009. e-Pub 2009.
140. Gaur R, Correa AM, Huang JL, Hofstetter W, Maru D, Mehran R, Roth JA, Vaporciyan AC, Walsh GL, Swisher SG. Correlation of endoscopic tumor length with lymph node involvement and poor long-term survival in esophageal cancer patients. 2009 Gastrointestinal Cancers Symposium. San Francisco, CA. January 15-17, 2009, 2009. e-Pub 2009.
141. Blackmon S, Shah N, Correa AM, Benjamin R, Hofstetter W, Lev D, Pollock R, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran R. Complete resection of extra-pulmonary sarcomatous metastases in addition to pulmonary metastasectomy is associated with long-term survival. The Society of Thoracic Surgeons 45th Annual Meeting, 2009. e-Pub 2009.
142. Cen P, Ajani JA, Correa AM, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA. Adenocarcinoma of the lower esophagus with Barrett’s or without Barrett’s: differences in patients survival after preoperative chemoradiation. ASCO Annual Meeting, 2008. e-Pub 2008.
143. Bolton W, Hofstetter WL, Francis A, Correa AM, Ajani JA, Bhutani B, Erasmus J, Komaki R, Maru D, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length and submucosal involvement on the long-term survival of pT1 early stage esophageal adenocarcinoma. The 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, California, 2008. e-Pub 2008.
144. Vaporciyan AA, Bashkar S, Correa AM, Mendoza T, Hofstetter WL, Rice DC, Mehran RJ, Swisher SG, Wang XS, Cleeland C. A novel system for measuring longitudinal postoperative symptom burden: proof of concept comparing VATS versus open lobectomy. ISMICS 2008 Annual Scientific Meeting, 2008. e-Pub 2008.
145. Fukami N, Dekovich AA, Hofstetter WL. Multifocal high-grade dysplasia (MFHGD) in Barrett’s esophagus is associated with adenocarcinoma in patients undergoing endoscopic mucosal resection (EMR) for Barrett’s esophagus. Digestive Disease Week 2008, 2008. e-Pub 2008.
146. Fukami N, Dekovich AA, Hofstetter WL, Shah RJ, Sericati MR, Brauer BC, Sethi A, Khan AH, Chen YK. Frequency and risk factors of esophageal stricture after endoscopic mucosal resection (EMR) for Barrett’s esophagus with high-grade dysplasia (HGD) or adenocarcinoma (CA). American Society for Gastrointestinal Endoscopy (Oral or Poster, Digestive Disease Week 2008), 2008. e-Pub 2008.
147. Bolton W, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter WL, Komaki R, Mehran RJ, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Long-term survival with surgical management for superior sulcus tumors with vertebral resection. The 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, California, 2008. e-Pub 2008.
148. Mehran R, Shah N, Correa A, Vaporciyan A, Rice D, Hofstetter W, Walsh G, Benjamin R, Swisher S, Pollock R, Roth J. Pulmonary Metastatectomy In Sarcoma Patients With Extra-Thoracic Metastases. 18th World Congress of the World Society of Cardio-Thoracic Surgeons, 2008. e-Pub 2008.
149. Maru DM, Khurana H, Correa AM, Swisher SG, Ajani JA, Rashid A, Hofstetter WL. Clinicopathologic Features and Prognosis of High-Grade Neuroendocrine Carcinoma of Esophagus. United States and Canadian Academy of Pathology, 2008. e-Pub 2008.
150. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele N, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the Revised Lung Cancer Staging System (IASLC Staging Project) to a Cancer Center Population. Proc Am Assoc Thorac Surg, 2008. e-Pub 2008.
151. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of Endoscopic Ultrasound Staging in Conjunction with Evaluation of Lymphovascular Invasion in Identifying Low-Risk Esophageal Carcinoma. Texas Society of Medical Oncology, 2007. e-Pub 2007.
152. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Maru D, Rashid A, Ajani JA. Lymphovascular Invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. International Society of Gastrointestinal Oncology, 2007. e-Pub 2007.
153. Liang J, Rashid A, Wu TT, Correa AM, Maru D, Corley LJ, Hofstetter WL, Swisher SG, Ajani JA, Hamilton SR, Wang H. High level of nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (hTERT) is associated with better prognosis in patients with esophageal and esophagogastric junction adenocarcinomas. American Association for Cancer Research, 2007. e-Pub 2007.
154. Dang A, Grosshans D, Schier R, Aguilar J, Hofstetter W, Mehran R, Hernandez M, X-G S, Cox J, Riedel B, Hightower C. Quantifying the physiologic effects of neoadjuvant chemoirradiation on patients with carcinoma of the esophagus by integrative cardiopulmonary exercise testing (CPET). American Radium Society Annual Meeting, Amsterdam, Holland, 2007. e-Pub 2007.
155. Blackmon SH, Rice DC, Correa AM, Hofstetter WL, Swisher SG, Mehran R, Vaporciyan AA, Walsh GL, Roth JA. Does a gastrostomy tube versus jejunostomy tube prior to esophagectomy for primary esophageal cancer patients have additional risk?. Society of Thoracic Surgeons, 2007. e-Pub 2007.
156. Javeri HA, Arora R, Correa AM, Dixon DR, Komaki R, Hofstetter WL, Rice DC, Walsh GL, Vaporciyan AA, Swisher AG, Lee JH, Bhutani M, Ross WA, Liao Z, Maru DM, Dekovich AA, Ajani JA. Comparison of the outcomes of patients with localized esophageal carcinoma receiving bimodal therapy versus trimodal therapy. International Society of Gastrointestinal Oncology (Poster presentation), 2007. e-Pub 2007.
157. Swisher SG, Winters K, Komaki R, Ajani J, Wu T, Hofstetter WL, Konski A, Willett C. A Phase II study of a Paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer. American Society for Therapeutic Radiology and Oncology, 2007. e-Pub 2007.
158. Rice DC, Correa AM, Hofstetter WL, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA, Roth JA. Recent survival trends for clinically staged stage I lung cancer. Society of Thoracic Surgeons, 2007. e-Pub 2007.
159. Yendamuri S, Walsh G, Vaporciyan A, Hofstetter W, Rice DC, Mehran RJ, Roth JA. Comparison of limited surgery and 3D conformal radiation in high risk patients with stage IA non small cell lung cancer: A propensity score matched analysis. J Thorac Oncol 2(8):S388, 2007. e-Pub 2007.
160. Blackmon SH, Correa AM, Wynn B, Martin LW, Hofstetter WL, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity matched analysis of three techniques for intrathoracic esophagogastric anastomosis. STSA 53rd Annual Meeting 83(5):1805-13; discussion 1813, 2006. e-Pub 2006. PMID: 17462404.
161. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased Risk of Aspiration and Pulmonary Complications after Lung Resection in Head and Neck Cancer Patients. STS 42nd Annual Meeting:214, 2006. e-Pub 2006.
162. Brown K, Bisanz A, Walsh G, Vaporciyan A, Hofstetter W. A Proactive approach to preventing constipation in postoperative oncology pulmonary resection patients. Oncology Nursing Forum 33:414, 2006. e-Pub 2006.
163. Rice DC, Stevens C, Forster K, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Survival and recurrence patterns following extrapleural pneumonectomy and intensity modulated radiation therapy for malignant pleural mesothelioma. Southern Thoracic Surgical Association, 2006. e-Pub 2006.
164. Liu H, Blackmon S, Gayed I, MD, Wang X, Wei X, Tucker S, Liao Z, Hofstetter WL, Swisher SG, Mohan R, Komaki R. Cardiac toxicity from chemoradiation with or without surgery in esophageal cancer patients. American Society for Therapeutic Radiology and Oncology, 2006. e-Pub 2006.
165. Hofstetter W, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu TT, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Proposed Modifications of Nodal Status in AJCC Esophageal Cancer Staging System. 53rd Annual Meeting Southern Thoracic Surgeon’s Association, 2006. e-Pub 2006.
166. Wu TT, Chirieac LR, Abraham SC, Krasinskas A, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma following preoperative chemoradiation in esophageal carcinoma: A reliable predictor for patient outcome. Mod Pathol 19(1):124A, 2006. e-Pub 2006.
167. Albarracin CT, Resetkoval E, Wang H, Anderson P, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Wu TT. Expression of Annexin A1 in esophageal and esophagoastric junction adenocarcinomas: association with poor outcome. Mod Pathol 19(1):100A, 2006. e-Pub 2006.
168. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe RJ, Walsh GL. Long segment supercharged pedicled jejunal flap for total esophageal reconstruction. Proc Am Assoc Thorac Surg 98(5):1391-8, 2005. e-Pub 2005. PMID: 16256794.
169. Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe WR, Putnam Jr JB, Hofstetter W, Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagogastric junction adenocarcinoma treated with preoperative chemoradiation. 2005 ASCO Annual Meeting 23(16S):319, 2005. e-Pub 2005.
170. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. STS 2005, 2005. e-Pub 2005.
171. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially respectable malignant mesothelioma. 41st Annual Meeting Society of Thoracic Surgeons, 2005. e-Pub 2005.
172. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-Identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus. American Association for Thoracic Surgery's 85th Annual Meeting. San Francisco, California:102-103, 2005. e-Pub 2005.
173. Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe RW, Putnam JB, Hofstetter WL, Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA. Outcomes for resected stage IIIA Non-Small Cell Lung Cancer over 15 years at a single institution. American Association for Thoracic Surgery's 85th Annual Meeting. San Francisco, California:72-73, 2005. e-Pub 2005.
174. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG. The Addition of Induction Chemotherapy to Preoperative Concurrent Chemoradiotherapy Improves Tumor Response in Patients with Esophageal Adenocarcinoma. Western Thoracic Surgical Association, 2005. e-Pub 2005.
175. Liu L, Hofstetter W, Rashid A, Swisher S, Correa A, Hamilton S, Wu TT. Significance of the Depth of Tumor Invasion in Early (T1) Esophageal Adenocarcinoma. Mod Pathol 18(1):110A, 2005. e-Pub 2005.
176. Martin LW, Swisher SG, Hofstetter W, Correa AM, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. American Surgical Assoc:64, 2005. e-Pub 2005.
177. Swisher SG, Hofstetter WL, Correa AM, Jr PJ, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Evolving treatment outcomes of resected esophageal cancer over three decades for 951 patients at a single institution. American Surgical Association's 122nd Annual Meeting. Hot Springs, Virginia, 2002. e-Pub 2002.
178. Hooda Z, McCracken A, Carbone G, Luna AM, Antonoff MB, Correa AM, Mehran RJ, Mitchell KG, Rajaram R, Rice DC, Swisher S, Vaporciyan A, Walsh G, Hofstetter WL. The Impact of Adjuvant Therapy on Pathologic T1N1 Esophageal Adenocarcinoma Outcomes: A National Cancer Database Propensity-Matched Analysis. AATS.
179. Hooda Z, McCracken A, Carbone G, Hofstetter WL, Mehran R, Rajaram R, Rice D, Swisher S, Vaporciyan A, Walsh G, Mitchell KG, Antonoff MB. Are BoneMetastases A contraindication? Role of Surgical Consolidation in EGFR-Mutated Stage IV NSCLC Patients Receiving Osimertinib. IASLC / ASCO 2025 North America Conference on Lung Cancer.

Book Chapters

1. Betancourt Cuellar, SL, Benveniste, MK, Palacio, D, Hofstetter, WL, Marom, EM. Esophageal Cancer, 218-233, 2022.
2. van der Wilk BJ, Eyck BM, Hofstetter WL, Ajani JA, Piessen G, Castoro C, Alfieri R, Kim JH, Kim SB, Furlong H, Walsh TN, Nieboer D, Wijnhoven BPL, Lagarde SM, van Lanschot JJB. Chemoradiotherapy Followed By Active Surveillance Versus Standard Esophagectomy For Esophageal Cancer: A Systematic Review And Individual Patient Data Meta-Analysis. In: Eophageal Cance: Towards Active Surveillance. Erasmus University Rotterdam, 345-381, 2022.
3. Rajaram R, Spicer JD, Dhupar R, Kim JY, Sepesi B, Hofstetter WL. Esophagus. In: Sabiston Textbook of Surgery The Biological Basis of Modern Surgerical Practice. 21. Elsevier, 1014-1055, 2021.
4. Betancourt-Cuellar SL, Benveniste MFK, Palacio DP, Hofstetter WL. Esophageal Cancer: Tumor-Node-Metastasis Staging. In: Imaging Of The Mediastinum. 2, 219-229, 2021.
5. Bostock IC, Hofstetter WL. Paraesophageal Hernia. In: TSRA Review Of Cardiothoracic Surger. 2nd. TSRA/TSDA, 126-129, 2020.
6. Zhou N, Rajaram R, Hofstetter WL. Management of Locally Advanced Esophageal Cancer. In: Emerging Therapies in Thoracic Malignancies. 4. Elsevier, 631-646, 2020.
7. Hofstetter, WL. Esophageal Cancer. In: Encyclopedia of Gastroenterology. 2. Oxford: Academic Press, 321-327, 2020.
8. Kim MP, WL H. Primary Tumors of the Diaphragm. In: Shield's General Thoracic Surgery. 8th. Wolters Kluwer, 695-705, 2019.
9. Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SH. Prediction And Diagnosis of Interval Metastasis After Neoadjuvant Chemoradiotherapy For Esophageal Cancer Using PET/CT. In: Perioperative Management of Esophageal Cancer. Lucas Goense, Utrecht, 42-61, 2018.
10. Goense L, van Rossum PSN, Xi M, Maru DM, Carter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SH. Preoperative Nomogram to Predict Early Disease Recurrence After Neoadjuvant Chemoradiotherapy And Surgery For Esophageal Adenocarcinoma. In: Perioperative Management Of Esophageal Cancer. Lucas Goense, Utrecht, 102-117, 2018.
11. Rajaram R, Hofstetter WL. Mucosal Ablation Techniques For Barrett's Esophagus and Early Esophageal Cancer. In: Thoracic Surgery Clinics - Innovations In The Management Of Foregut Disease. 4. Elsevier, 473-480, 2018.
12. Hofstetter WL. Section IV Esophagus. In: Operative Standards for Cancer Surgery Vol. 2. Wolters Kluwer, 249-375, 2018.
13. Spicer JD, Hofstetter WL. Lung Cancer: Stage III and IV. In: Textbook of Complex General Surgical Oncology. 1st. McGraw Hill Education, 651-663, 2018.
14. Hofstetter WL. Multimodality Treatment for Potentially Resectable Esophageal Cancer. In: Shackelford’s Surgery of the Alimentary Tract. Eighth Edition. Elsevier, 382-390, 2018.
15. Mitchell KG, Nelson DB, Hofstetter WL. Squamous Cell Carcinoma of the Esohagus. In: Complex General Surgical Oncology. Decker, 2018.
16. Sepesi B, Hofstetter WL, Swisher SG. Multimodality Therapy for Esophageal Cancer: Western Experience Including Definitive Chemoradiation. In: Textbook of Complex General Surgical Oncology. 1st. McGraww Hill Education, 953-962, 2018.
17. Rice TW, Kelson D, Blackstone EH, Ishwaran H, Patil DT, Bass AJ, Erasmus JJ, Gerdes H, Hofstetter WL. Esophagus and Esophagogastric Junction. In: AJCC Cancer Staging Manual. 8th. Springer, 185-202, 2017.
18. Coit DG, Kelsen D, Tang LH, Erasmus JJ, Gerdes H, Hofstetter WL. Small Intestine. In: AJCC Cancer Staging Manual. 8th. Springer, 221-234, 2017.
19. Ajani JA, In H, Sano T, Gaspar LE, Erasmus JJ, Tang LH, Washington MK, Gerdes H, Wittekind CW, Mansfield PF, Rimmer C, Hofstetter WL, Kelson D. Stomach. In: AJCC Cancer Staging Manual. 8th. Springer, 203-220, 2017.
20. Sepesi B, Hofstetter W. Advanced Surgical Approaches for the Management of Esophageal Carcinoma. In: Principles and Practice of Radiortherapy Techniques in Thoracic Malignancies. Springer International Publishing, 345-362, 2016.
21. Hofstetter WL, Sepesi B. Multimodality Therapy for Esophageal Cancer. In: Surgery of the Chest. 9, 688, 2016.
22. Hofstetter WL. Oesophageal Reconstruction: Supercharged and Superdrained Conduit. In: ESTS Textbook of Thoracic Surgery. Medycyna Praktyczna, 2015.
23. Hofstetter WL. Options for Esophageal Replacement. In: Adult Chest Surgery. Second, 196, 2015.
24. Sepesi B, Hofstetter WL. Open Technique for Ivor Lewis Esophagectomy. In: Surgery for Cancers of the Gastrointestinal Tract, 2015.
25. Blackmon SH, Hofstetter WL. Long Segment Reconstruction with Jejunum. In: Master Techniques in Surgery, Esophageal Surgery. Wolters Kluwer, 307, 2014.
26. Bruzzi J, Marom E, Hofstetter WL, McAleer M. Esophageal Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Saunders Elsevier, 2010.
27. Hofstetter WL. Salvage Esophagectomy for Persistent Disease After Definitive Chemoradiotherapy. In: Difficult Decisions in Thoracic Surgery, 2010.
28. Kim JY, Hofstetter WL. Tumors of the Mediastinum and Chest Wall. In: Surg Clin North Am. 5. Saunders, 1019-1040, 2010.
29. Hofstetter WL. Principles of surgical therapy. In: Esophageal Cancer: Principles and Practice. Demos Medical Publishing, 277-282, 2009.
30. Hofstetter WL. Management options for Barrett's esophagus with dysplasia. In: Advanced Therapy in Surgical Oncology. BC Decker Inc, 25-32, 2008.
31. Al-Refaie WB, Hofstetter WL. Multimodality treatment of esophageal cancer (Chapter 36). In: Surgery of the Alimentary Tract. Sixth Edition. Saunders, 499-512, 2007.
32. Hofstetter WL. Esophageal conduits and palliative procedures. In: Mastery of Cardiothoracic Surgery. Second. Lippincot Williams & Wilkins, 174-186, 2007.
33. Hofstetter WL, Swisher SG. Lymph node dissection in esophageal cancer. In: Current Therapy in Thoracic and Cardiovascular Surgery. Mosby, 360-363, 2004.

Letters to the Editor

1. Hofstetter WL, Swisher SG, and Ajani JA. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma (Author reply to Correspondence). Cancer 109: 1449, 2007.
2. Hofstetter WL, Ly P, Anthone G, Ortega AE, Vukasin P, RW Jr AB. Prevalence and distribution of anorectal misdiagnoses. West J of Med 168: 549, 1998.